Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2020-12-11

Identification of Genes that Determine Fitness, Virulence, and
Disease Outcomes in Mastitis Associated Eschericia coli
Michael Andrew Olson
Brigham Young University

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Life Sciences Commons

BYU ScholarsArchive Citation
Olson, Michael Andrew, "Identification of Genes that Determine Fitness, Virulence, and Disease Outcomes
in Mastitis Associated Eschericia coli" (2020). Theses and Dissertations. 9307.
https://scholarsarchive.byu.edu/etd/9307

This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more
information, please contact ellen_amatangelo@byu.edu.

Identification of Genes that Determine Fitness, Virulence,
and Disease Outcomes in MastitisAssociated Escherichia coli

Michael A. Olson

A dissertation submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy

David L. Erickson, Chair
Eric Wilson
Joel S. Griffitts
William R. McCleary
John M. Chaston

Department of Microbiology and Molecular Biology
Brigham Young University

Copyright © 2020 Michael A. Olson
All Rights Reserved

ABSTRACT
Identification of Genes that Determine Fitness, Virulence,
and Disease Outcomes in MastitisAssociated Escherichia coli
Michael A. Olson
Department of Microbiology and Molecular Biology, BYU
Doctor of Philosophy
Escherichia coli is an incredibly diverse group of bacteria that consist of both commensal
and pathogenic strains that cause disease in a wide variety of tissues in many different animals.
The current dogma, based on years of extensive molecular and genetic studies, is that individual
strains have adapted to specific environments through acquisition of specific genes or come from
lineages that are particularly suited to a unique tissue or host. However, mastitis-associated E.
coli (MAEC) have thus far resisted such descriptions. The fitness and virulence factors of MAEC
are poorly understood and molecular tools are rarely applied. This dissertation reports new
approaches to assess virulence of MAEC strains, enabling comparative genomic studies across
multiple strains as well as genome-wide analysis of specific successful MAEC isolates. I outline
the identification of the first virulence factor of MAEC, a ferric dicitrate receptor that is essential
for colonization of a lactating mammary gland in a murine model. Genes previously studied in
the contexts of other extraintestinal E. coli infections were also implicated in mastitis. These
include a type III capsule found in the MAEC strain M12, which is crucial for dissemination
from the mammary gland to the spleen. A mutant unable to produce capsule had diminished
lethality in Galleria mellonella and decreased kidney colonization in a mouse urinary tract
infection. I also report a link between zinc uptake, bile salts, and capsule production.
I have utilized a transposon mutant library paired with deep sequencing of transposon
junctions to elucidate the fitness factors needed to grow in milk and colonization of both murine
and insect models. This analysis implicates a broad set of genes and metabolic pathways
pertinent to these conditions. In addition to Tn-seq, I sequenced 94 MAEC genomes and
identified genes associated with disease severity, growth in milk, and colonization of mammary
glands in cow and mouse models. Employing bioinformatic tools to interrogate the pan-genome,
I identified genes that are involved in biofilm formation and adhesion that were specifically
associated with either mild or severe disease. In summary, I have employed several powerful
genetic, genomic, computational, and molecular approaches to the characterization of mastitis
associated E. coli. This work provides the groundwork for future experiments to better
understand the host-pathogen interface and a model for mastitis-associated E. coli.
Keywords: mastitis, Tn-seq, GWAS, capsule, iron uptake, Escherichia coli, zinc, capsule
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Chapter 1 Introduction
1.1 Mastitis
Mastitis is defined as the inflammation of the mammary tissue and is caused by several
factors, including trauma, metabolic and physiologic changes. It is most commonly the result of
an infectious pathogen. All mammals are susceptible to mastitis, including humans. Around 20%
of lactating women in developed counties [1-4] are affected by the painful symptoms of mastitis.
It is a substantial economic burden to the dairy industry, which incurs billions of dollars of losses
each year in the form of treatment and decreased milk production, culling, and death [5,6]. For
these reasons, there is a strong desire to understand the mechanisms that control mastitis
susceptibility and define the features of bacterial pathogens that cause the majority of cases.
1.1.2 Both contagious and environmental pathogens are known to cause mastitis
Contagious mastitis pathogens are adapted to survive within the mammary gland and are
thought to be spread from cow to cow through contaminated milking equipment. Once
established within the mammary gland, these pathogens can cause increased somatic cell counts
in the milk and persistent subclinical infections. Common contagious pathogens
include Staphylococcus aureus, Streptococcus dysgalactiae, coagulase-negative staphylococci,
and Streptococcus agalactiae [7-9]. Due to improved herd management, cleaning milking
equipment, and effective antibiotic treatment, there has been a decreased incidence of mastitis
caused by contagious pathogens, but they still remain a serious concern.
Environmental mastitis pathogens are not thought to survive for long periods in the
mammary gland and thus do not usually spread from cow to cow. The major environmental
pathogens include Escherichia coli and Streptococcus uberis [10-12]. E. coli is a major
environmental pathogen capable of infecting multiple tissue sites and hosts. Recent evidence
1

suggests that some E .coli have specifically adapted to colonize the mammary gland, in addition
to thriving in the digestive tracts of cattle. These strains may cause recurring infections of the
mammary glands, may spread within quarters, and invade underlying tissues. They can result in
sepsis and death in extreme cases. This group of bacteria is referred to as mastitis-associated E.
coli (MAEC) or alternatively mammary-pathogenic E. coli (MPEC). The MPEC designation
would imply that these bacteria form a separate pathotype along with others, including avian
pathogenic (APEC) or uropathogenic (UPEC) E. coli. The existence of a distinct pathotype has
been disputed. As the incidence of mastitis cases caused by E. coli increases even in wellmanaged dairy herds, there is an increased interest in understanding and elucidating virulence
factors of MAEC, such as adherence, colonization, and nutrient acquisition.
Prior to work described in this dissertation, the genetic features of MAEC were poorly
understood. Studies investigating the relative virulence of MAEC strains were lacking, and
modern molecular tools have rarely been applied to the study of MAEC. The prevailing view has
been that mastitis severity is due to cow factors alone and that all E. coli can cause mastitis. The
development of disease has been ascribed solely to the elicitation of inflammatory reactions due
to lipid A or other innate immunity triggers conserved in all E. coli. A few recent studies have
begun to question this paradigm [13-18]. Additionally, the relationship between MAEC and
other extraintestinal pathogenic E. coli (ExPEC) has been unclear. Indeed, mastitis strains have
been considered as commensal strains with little to no potential to cause disease. However,
ExPEC are emerging as some of the most important pathogens of humans and animals. It is
crucial to identify all of the potential reservoirs of these strains.
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1.1.3 Mastitis-associated E. coli (MAEC)
The previously dominant view of mastitis caused by E. coli (or coliform mastitis) was
that any introduction of these bacteria into the mammary gland would be sufficient to cause
disease, and the severity of the disease was entirely due to cow factors that control susceptibility
to infection or the strength of the inflammatory response [19]. There are several clearly
understood cow factors that increase the risk of infection. Cows at the time of parturition and
early stages of lactation are more prone to infection and develop more severe symptoms due to
negative energy balance [20-24]. At this time there is a decrease in oxidative burst activity and
neutrophil function [25]. Conversely, the bacterial virulence and fitness factors of MAEC strains
that could determine the likelihood or severity of disease are not understood.
In recent years there has been an adjustment to this view, as evidence that commensal
strains of E. coli are unable to cause persistent or acute mastitis accumulates [26,27]. Prior to this
work, there was little understanding of bacterial factors that contribute to severity of mastitis.
There is an understanding now that both cow and bacterial factors are important in the
pathogenesis of mastitis caused by MAEC strains.
To cause mastitis, the bacteria must first gain entry into the mammary gland lumen via
the teat canal. Once in the mammary gland, there are innate immune barriers including specific
antimicrobial proteins and nutrient-limiting factors that the bacteria need to overcome to colonize
this tissue site successfully [28-32]. Neutrophil influx is a feature of mastitis. Presumably the
bacteria must be able to resist phagocytosis or survive despite degranulation and release of
extracellular traps. There has not been any consistent pattern of gene content or phylogenetic
background that can be assigned to any of these abilities in MAEC strains.
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Studies attempting to identify MAEC-associated genotypes or understand their
relationship to other E. coli have been conducted. MAEC isolates often belong to the phylogroup
A and possess a variety of O polysaccharide and flagella antigens [33-37]. Multilocus sequence
typing (MLST) of MAEC strains reveals that strains come from diverse sequence types (ST),
including pandemic ExPEC lineages. Putative virulence factors that have been identified in
MAEC strains include lipopolysaccharide, adhesion fimbriae, and iron acquisition systems
[26,38].
1.2 Potential Virulence factors of MAEC
1.2.1 Lipopolysaccharide
Lipopolysaccharide (LPS) is a considerable virulence determinant in many Gramnegative bacteria. It has three components, including the hydrophobic membrane anchor lipid A,
the core oligosaccharide, and a polymer of glycosyl units known as the O polysaccharide or O
antigen. The O antigen has immense diversity within E. coli with over 180 recognized serotypes
and has been implicated in resistance to antimicrobial peptides and complement proteins. Despite
the O antigen diversity, its structure is synthesized by one of three pathways: Wzy dependent,
ABC transporter dependent, and synthase dependent. Of these three pathways the Wzy
dependent pathway is the most common. The core oligosaccharide region can be subdivided into
two regions; the inner and outer core. The inner core is well conserved amongst E. coli strains
and is made of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) and L-glycero-D-mannoheptopyranose (Hep). The outer core consists of glycose residues, differing in the specific sugar
moieties and the linkages between them, and exhibits more diversity. There are five core types
found in E. coli (K-12, R1, R2, R3, and R4) defined by differences located in the outer core.
Mutations resulting in the core truncation can cause growth defects due to the core's importance
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in limiting outer membrane permeability. Specific O-antigen types have not been linked to
MAEC strains' virulence, but most strains are resistant to complement and serum due to the Oantigen's full length or smooth configurations [39-42].
Additionally, the LPS components likely help MAEC resist soluble antimicrobial
defenses in milk such as lysozyme and antimicrobial chemokines [43,44]. Other mechanisms are
also likely at play, such as the increased serum survival gene iss and capsule polysaccharides.
Lipid A is identified by Toll-like receptor 4 (TLR-4), a receptor of the innate immune system
found on the surface of macrophages and endothelial cells [45]. Activation of TLR-4 triggers the
upregulation of critical proinflammatory cytokines such as TNF-α and IL-1β. Some bacteria can
modify their lipid A, making it more resistant to antimicrobial peptides. This process is done by
biosynthesis of arabinose and its attachment to the core-lipid A, facilitated by the pmr operon
[46].
1.2.2 Adhesins
The ability of bacteria to attach and adhere to surfaces is vital for their pathogenesis and
is a prerequisite for biofilm formation. Gram-negative bacteria employ many different types of
pili or fimbriae for these purposes. The predominant type of fimbriae associated with and utilized
by ExPEC strains are Chaperone-usher (CU) fimbriae and curli pili. Type 1, afa, S, and P
fimbriae are CU types of fimbriae that play essential roles in ExPEC pathogenesis [47]. P
fimbriae are another well-studied CU fimbria primarily found within UPEC strains and are
strongly associated with acute pyelonephritis [48-51].
Recently, an additional CU fimbria encoded by the yad genes has been shown to be
important for virulence of urinary pathogenic E. coli (UPEC) and avian pathogenic E.
coli (APEC) [52-55]. A screen of CU fimbriae of 35 E. coli strains representing several different

5

pathogenic phylogenetic lineages found 38 distinct fimbrial types, highlighting the diversity of
these adhesins in E. coli [56].
Fimbrial biogenesis by the CU pathway requires two proteins. A chaperone located at the
periplasm facilitates the folding, prevents polymerization, and directs the fimbrial subunits to the
usher protein, which in turn acts as an assembly platform at the outer membrane and exports the
structure outside the cell (Fig.1.1). The most common CU fimbriae found in commensal and
MAEC strains are the D-mannose specific type 1 fimbriae (fimAICDFGH). In one study,
the fimH gene was the only virulence-associated gene detected in all MAEC isolates [57].
The fimAICDFGH operon encodes the fimbrial biosynthesis machinery, structural components,
and fimbrial regulatory elements. The fimAICDFGH operon's promoter is subjected to inversion
by two tyrosine-class recombinases, FimE and FimB, which generate phase variable expression
of the Type 1 fimbriae [58-60]. Binding to mannose is mediated by FimH adhesin, which is
located at the tip of the structure. FimH has been implicated in biofilm formation [61]. Blocking
FimH with mannose diminished adhesion and invasion of MAEC isolates in bovine mammary
epithelial (MAC-T) cells. Two MAEC isolates carried a polymorphism in FimH (A27V) that
increased adherence to MAC-T cells [62]. The same A27V polymorphism has been reported to
confer pathoadaptive advantages in the virulence of some uropathogenic E. coli [63].
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Figure 1.1 Schematic of two chaperone–usher pili systems.
The type 1 and P fimbria found in E.coli. Each fimbriae is assembled using a combination of
subunits (Fim or Pap). These fimbriae are made of two distinct regions: a flexible tip and a rigid
rod. The fimbriae are anchored to the outer membrane by the usher and at the tip is the lectin
binding site. The usher consists of a transmembrane pore domain and four soluble domains
found in the periplasmic space: the N-terminal domain (N), the plug domain (P), and the Cterminal domains (C1 and C2). Figure and legend adapted from reference [64]
No universal pattern of pili or fimbrial genes have been associated with MAEC strains,
and few functional studies of pili in colonizing mammary glands have been reported. MAEC
frequently carry genes encoding curli pili but their role is unclear [65]. To date, there has been no
specific adhesin linked to MAEC pathogenesis and they remain putative virulence factors only.
Interestingly, P fimbriae are not universally found in MAEC, but some studies find that they are
associated with strains that cause persistent mastitis infections [66]. Other ExPEC virulence
genes are also found in these strains. This suggests some MAEC strains may be able to colonize
other tissue sites; an idea that is explored further in chapter three of this dissertation, where
evidence is presented that the MAEC strain M12 is indeed able to infect multiple tissue sites.
7

1.2.3 Polysaccharide capsule
Some bacterial pathogens produce capsules to protect against environmental stress or are
needed to survive within a host. Within a host, the capsule may protect against cellular and
soluble immune factors. Like the O antigen, the capsule can play a major or minor role in
protecting some strains of E. coli from complement membrane attack complex (MAC),
complement-mediated opsonization by phagocytes, and survival in the urinary tract [67-69].
Also, the capsule often has a negative charge; this can protect against cationic antimicrobial
peptides (CAMPs), which are positively charged peptides that disrupt the outer membrane by
binding to the CAMPs, keeping them a safe distance from the outer membrane [70,71].
A majority of capsules are polysaccharides consisting of repeating monosaccharides or
oligosaccharides that are either covalently bound or loosely associated with the outer membrane.
Polysaccharide capsules constitute a significant virulence determinant for many important human
and animal pathogens that include Haemophilus influenzae, Neisseria meningitidis, Klebsiella
pneumoniae, and both intestinal and ExPEC strains of E. coli. In E. coli, there are over 80
capsule (K) antigens that can be grouped into four capsule groups depending on the genetic,
biosynthesis, and export mechanisms used in creating the capsule[72,73].
Group 1 and 4 capsules are similar, and are often found in E. coli isolates that cause
intestinal infections. They rely on a Wzy-dependent biosynthesis system and share genetic
features with O-antigen loci, but differ in their organization and distribution. In simplified terms,
Group 1 and 4 capsule biosynthesis begins in the cytoplasm where monomer units (CPS) are
linked to undecaprenyl pyrophosphate (und-pp) on the cytoplasmic-facing inner membrane.
Nascent und-pp-linked CPS units are then flipped across the inner membrane by Wzx. Once in
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the periplasmic space, Wzy-dependent polymerization of sugar repeats occurs. Finally, the
polymer is translocated to the outer membrane by Wza on the cell surface.
Conversely, Group 2 and 3 capsules are associated with extraintestinal infections. Both
are similar in that they are synthesized by ABC transporter-dependent pathways. They vary
significantly in their sugar moieties and repeat numbers. Group 2 and 3 capsules have three
distinct gene clusters involved in capsule biosynthesis; terminal regions 1 and 3 contain genes
mostly shared by both groups, while the central region 2 contains genes for the serotype-specific
repeat unit of group 2 and 3 capsules. The conserved genes in group 2 capsules
are kpsFEDUCS in region 1 and kpsTM in region 3. Conserved genes in group 3 capsules
are kpsDMTE in region 1 and kpsCS in region 3, but they lack kpsU and kpsF, which are
involved in CMP-3-deoxy-d-manno-oct-2-ulosonic acid (Kdo) biosynthesis. For group 2
capsules, KpsS initiates capsule synthesis by transferring a single Kdo sugar residue to a
lysophosphotidylglycerol anchor on the inner membrane's cytoplasmic facing side, and KpsC
extends this linker by adding 4-8 additional Kdo residues [74,75]. The attachment linker is not
known for group 3 capsules, but both KpsS and KpsC are essential to initiate capsule synthesis in
group 3 capsules, and kpsD, kpsE, and kpsC cloned from a group 3 capsule were able to
complement corresponding group 2 capsule mutants, indicating conserved protein function [76].
Since KpsU and KpsF are missing in group 3 capsules, there is some suspicion that the linker is
more complex in group 3 capsules, and the genes involved for linker synthesis are not found in
region 1 as in group 2 capsules but found in the serotype-specific region 2 [77].
After the linker synthesis is complete, the serotype-specific polymer structure is
assembled by the action of glycosyltransferase enzymes that transfer specific sugars to the
growing glycan chain until completed [78,79]. For example, the K54 capsule found in the
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ExPEC strain CP9 has a composition of approximately 380 repeating D-glucuronic acid and Lrhamnose residues, where 85% of the glucuronic acid residues are amidically linked with either
L-threonine or L-serine [80]. The K96 capsule found in the MAEC strain M12 is very similar
and cross-reactive to the K54 capsule but lacks amidically linked amino acids [81]. Besides the
amino acid decoration of the glycan chain in K54, some capsule polysaccharides are acetylated
under certain conditions [82]. The function of modifications to the CPS are not fully understood,
but the acetylation of the K1 capsule found in meningitis-causing strains is correlated with
disease severity in patients with sepsis [83]. However, in a rat model of meningitis CPS,
acetylation was lost once the bacteria moved from the meninges to the bloodstream, which
indicates that CPS modifications may be important for the colonization of some tissue sites but
dispensable in others [84]. Once the CPS synthesis is complete, it is transported across the inner
membrane and periplasmic space by an ABC dependent transporter comprising two identical
nucleotide-binding domain proteins, KpsM and KpsT, to the outer membrane through a capsular
polysaccharide translocation channel, KpsD, which requires KpsE for its proper localization
(Fig. 1.2).
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Figure 1.2 Schematic of the genetic locus of a group 2 and 3 capsule.
Regions 1 & 3 consist of conserved regions of group 2 & 3 capsules; this region has genes for
capsule initiation and export. Group 3 capsules lack kpsU and kpsF in region 1 which are
necessary for KDO sugar biosynthesis. Region 2 contains genes for the CPS biosynthesis which
are specific for each K-type. Rhamnose is a sugar often found in group 3 capsules.
In chapters 2 and 3 of this dissertation I investigate the role of the K96 capsule found in
the MAEC strain M12. I report a link between zinc uptake and capsule production. In some
tissue sites, capsule was required for bacterial colonization but was dispensable in others; this
provides evidence that certain virulence factors provide an adaptation for some ExPEC strains to
infect multiple tissue sites and blurs the distinction of pathotypes. Additionally, I show that strain
M12 is capable of colonizing both mammary glands and urinary tracts in mice; this raises the
question of whether dairy cattle may be a reservoir for urinary tract infections. This is consistent
with the emerging evidence linking a significant number of human infections with food-borne
APEC strains.
1.2.4 Iron acquisition
Iron is an essential metal and is needed in a myriad of biological processes, but its
availability is often limited. Due to iron's ability to exist in two oxidative states (ferrous (Fe2+)
or ferric (Fe3+), iron is vital as a catalyst for redox reactions to accept or donate electrons. As a
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result of these properties, excessive iron can lead to cellular toxicity, such as reactive oxygen
species produced by the normal cellular process. Iron can catalyze the Fenton reaction to
generate hydroxyl radicals that damage lipids, DNA, and proteins [85,86]. For these reasons,
bacteria and animals have developed sophisticated mechanisms to scavenge and sequester iron to
maintain iron homeostasis. In vertebrates, iron can be used in the biosynthesis of heme as a
prosthetic group for some metalloenzymes and the oxygen-binding moiety of hemoglobin or
incorporated into iron-sulfur complexes that act as redox cofactors for metalloenzymes. In the
cell, iron can be stored as ferritin, a large globular protein that can store up to 4000 iron ions
[87]. A majority of iron is contained in hemoglobin found in erythrocytes. Additionally, small
molecules like lactoferrin, transferrin, haptoglobin, and hemopexin will sequester any
extracellular iron. Within the mammary gland and other mucosal sites, lactoferrin is produced by
epithelial cells. Neutrophils recruited to infected mucosal tissues also secrete lactoferrin, which is
found in their secondary granules [88,89].
Bacteria have evolved several mechanisms to scavenge for iron, including siderophores,
heme acquisition systems, transferrin or lactoferrin receptors, and ferric or ferrous iron
transporters. Here, I will primarily focus on systems relevant to gram-negative bacteria,
specifically those employed by ExPEC strains.
Siderophores bind with a greater affinity to iron than host proteins. Once loaded with
iron, the ferric (Fe3+)-siderophores complex is brought back into the bacterial cell via the energy
transducing Ton-dependent receptors [90,91]. Ferrous (Fe2+) iron is rarely present in the
extracellular milieu and is often bound to heme or other iron sequestering small molecules.
Under anaerobic conditions or low pH, ferrous iron can cross the outer membrane through
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nonspecific porins. Once in the periplasmic space, ferrous iron can be shuttled across the inner
membrane by the ferrous iron FeoABC transport system [92].
Both commensal and pathogenic E. coli strains utilize siderophores to scavenge for iron
while in the host. The siderophore enterobactin is almost universally found in E. coli strains, and
once bound with ferric iron, it is internalized through the FepA receptor. To counteract the
effects of enterobactin, mammals produce lipocalin-2, which binds and inactivates enterobactin
[93,94]. In addition to enterobactin, ExPEC strains often produce additional siderophores and
dedicated receptors. Genes required for biosynthesis of salmochelin, aerobactin, or yersiniabactin
siderophores and their receptors are often found on plasmids or pathogenicity islands (PAIs).
Salmochelin is a glycosylated form of enterobactin and is internalized through the IroN receptor
but uses the same machinery as enterobactin to cross the inner membrane. Interestingly, the
salmochelin gene cluster's expression in a non-pathogenic strain of E. coli was able to confer
virulence in a mouse intraperitoneal infection model [95]. Aerobactin genes are often found on
colV plasmids in APEC strains. Aerobactin uptake involves both the outer membrane IutA
receptor and inner membrane FhuBC ABC-transporter; both salmochelin and aerobactin are
important in APEC ability to cause colibacillosis and airway infections in birds [96]. The FyuA
receptor and the YbtPQ ABC-transporter internalize yersiniabactin. The FyuA receptor promotes
biofilm formation in urine by UPEC strains, and immunization against the FyuA receptor
protected mice from pyelonephritis in a urinary tract infection caused by E. coli [97,98].
In addition to siderophores, some E. coli strains utilize iron complexed with citrate,
which is abundant in milk (0.15 to 0.25%) [99]. Citrate is produced by mammary epithelial cells
and chelates ferric iron. The FecA TonB-dependent receptor recognizes this ferric citrate, and
FecCDE ABC-transporter is needed at the inner membrane to bring the ferric citrate inside the
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cell where it is reduced to free the iron. Many MAEC strains carry the fec operon, and I show
experimentally in chapter 2 that the FecA receptor is essential for the colonization of the
lactating mouse mammary gland by the MAEC strain M12 but is dispensable for the colonization
of a non-lactating mammary gland. MAEC strains often carry other siderophores in addition to
the fec operon; M12 also has the genes needed for yersiniabactin biosynthesis.
1.3 Additional Metal acquisition
1.3.1 Copper
Like iron, other divalent cations play an essential physiological role in both bacteria and
host and several mechanisms to sequester and scavenge for these ions have evolved. Copper is an
important cofactor for a few key enzymes in the periplasm. These include cytochrome bo3
terminal oxidase subunit I (CyoB), NADH oxidoreductase II (Ndh-2), the amine oxidase TynA,
and CuZn superoxide dismutase SodC [100-103]. Copper concentrations are tightly regulated
and kept to a minimum in the cytoplasm. High levels of copper are toxic due to its ability to
tightly bind and displace iron in iron-sulfur clusters, which leads to the production of reactive
oxygen species (ROS). Copper may enter the cell through general bacterial porins like OmpC,
but copper permeability is limited by the outer membrane protein ComC [104].
Macrophages have evolved mechanisms to harness copper's toxic effects to combat
bacterial infections. After phagocytosis of bacteria, macrophages release interferon-γ, which
induces copper uptake in the cell. Copper is bound by ATOX-1 and brought to the phagosome
Cu transporter ATP7A, which subsequently increases the copper concentrations in the
phagosome to aid in the killing of the bacteria [105,106]. E. coli has mechanisms to export or
detoxify the effects of copper by actively transporting copper from the cytoplasm via the CopA
ATPase to the periplasm. The CusCBA transport complex exports copper to the extracellular
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milieu, and the multi-copper oxidase CueO detoxifies excess copper within the periplasm [107110]. In addition to these copper tolerance mechanisms, some ExPEC strains carry genes for the
biosynthesis of yersiniabactin, which has recently been shown to bind copper under
physiological conditions and reduce toxicity by binding host-derived Cu(II) and preventing its
reduction to Cu(I) [111].
1.3.2 Manganese
Manganese is an important cofactor in cellular processes that include lipid, protein, and
carbohydrate metabolism. During iron starvation or limiting conditions in Salmonella
enterica serovar Typhimurium, the iron sensing repressor Fur is deactivated, and manganese
transport is activated [112]. E. coli has enzyme redundancy that uses either iron or manganese as
a cofactor, which assists in metal limiting conditions. Notable examples include superoxide
dismutase (FeSOD and MnSOD) and ribonucleotide reductase (NrdAB and NrdEF); these
isozymes utilize manganese or iron as a cofactor [113-115].
The mechanisms whereby manganese is transported across the outer membrane in E.
coli are not fully understood. It may cross passively through outer-membrane porins or have an
undiscovered dedicated/promiscuous transport system. Once in the periplasm, manganese is
shuttled across the inner membrane by the Nramp-related transport system, MntH, or an ABC
transporter SitABCD. The ABC transporter SitABCD was first described in S. Typhimurium,
and MntH and SitABCD contribute to S. Typhimurium and Shigella flexneri virulence in mouse
models [116-119]. Additionally, there is evidence that the SitABCD is promiscuous in its ability
to transport iron and zinc. The SitABCD transporter is not universally found in E. coli, but genes
needed for its biosynthesis are often found in ExPEC strains; its role in pathogenesis is not fully
understood. SitABCD transport of manganese and iron promotes resistance to hydrogen
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peroxide, and a sitA mutant of an APEC strain displayed attenuated colonization in kidney, liver,
and lungs compared to the wild type strain in a chicken infection model [120,121].
1.3.3 Zinc
Zinc is an abundant transition metal utilized by bacteria, and zinc-binding proteins are a
significant fraction of a bacteria's proteome. It is estimated that 5-6% of proteins in the proteome
are zinc-binding proteins, which are predominantly comprised of enzymes [122]. Although zinc
cannot undergo redox reactions, it remains an essential nutrient due to its ability to function in
enzymes as a Lewis acid-type catalyst or for structural support [123]. Excess zinc is toxic, so
both bacteria and eukaryotic cells have evolved mechanisms to regulate and sequester zinc. Like
manganese, there are no known dedicated transporters of zinc across the outer membrane in E.
coli, but TonB-dependent outer membrane zinc transporter ZnuD may perform this function
in Neisseria meningitidis and Acinetobacter baumannii [124-127]. Interestingly, the siderophore
yersiniabactin produced by Yersinia pestis and several ExPEC strains, may be able to bind zinc
in addition to iron, acting as a zincophore [128]. Transport systems have been identified that
transport zinc from the periplasmic space across the inner membrane; namely ZupT, which
belongs to the ZIP (ZRT/IRT-like protein) family of transporters that are additionally found in
eukaryotes, and the high-affinity zinc ABC transporter ZnuABC.
Zinc is also an abundant and essential metal for vertebrates. Due to its essentiality for
pathogens, there are several mechanisms to sequester zinc as part of nutritional immunity. A
large portion of zinc is bound in a reversible manner by metallothionein and glutathione, which
act as a buffering system [129,130]. During an infection, the host will employ both cell-mediated
and extracellular processes to lower serum zinc concentrations. For instance, the ZIP Zn
importers and the Zn-transport exporters shuttle zinc from extracellular spaces or from
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intracellular vesicles and organelles [131]. The extracellular cellular sequestering of zinc
involves several S100 family members that form dimers that chelate metals at this interface. An
important S100 heterodimer calprotectin is formed by S100A8 and S100A9, creating two
binding sites. The first binds a broad range of metals that include Cu, Fe, Mn, Ni, and Zn and the
second selectively binds zinc with a high-affinity [132-136]. Calprotectin is commonly found at
infection sites, is a primary protein in the granules of neutrophils, and has been demonstrated to
limit bacterial growth in vitro and in vivo [127,137-142]. Additional S100 family proteins that
bind zinc are psoriasin (S100A7) and calgranulin C (S100A12). Psoriasin can bind two zinc ions
and is expressed at both the skin and mucosal sites, and there is some evidence it may be
important in limiting bacterial growth [143,144]. Calgranulin C binds both copper and zinc and
has been demonstrated to act as an antimicrobial, but its broader role in innate immunity has
been difficult to determine due to its absence in mice [145-147].
In response to host-inflicted metal starvation, bacteria have metalloregulators to sense ion
concentrations. In the case of zinc, the zinc uptake regulator (Zur) found in many pathogenic
bacteria is responsible for maintaining homeostasis. When zinc concentrations are typical, ZnZur forms a complex and binds DNA at a Zur box, blocking the transcription of zinc uptake
genes. When intracellular concentrations drop, zinc disassociates with Zur, lowing its binding
potential to the Zur box and allowing for transcription [148,149]. Important zinc transport
systems in E. coli pathogenesis are the ZupT and the high-affinity zinc ABC transporter
ZnuABC which are important for both intestinal and extraintestinal pathogenic strains [150,151].
In addition to zinc's above roles, in chapter 3 of this dissertation, I describe a novel link between
zinc homeostasis and capsule production in MAEC strain M12 and ExPEC strain CP9.
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1.4 Conclusions
In this dissertation, molecular genetic tools are applied to the study of MAEC strains
isolated from clinical cases of disease. I report identification of fitness and virulence factors,
antibiotic resistance, and zoonotic potential of MAEC strains. These include factors involved in
adherence, metal ion acquisition, immune avoidance, and metabolic adaptation.
In Chapter 2, I identify MAEC strains that are capable of causing severe disease and
focus on strain M12. M12 grows prolifically in milk and in mammary glands and can
disseminate to the spleens of mice. A genome-wide transposon sequencing approach is applied to
identify fitness factors in this strain that are needed for mammary gland colonization, as well as
growth in Galleria mellonella larvae. The critical role of the ferric dicitrate iron scavenging
system is uncovered. Furthermore, dissemination of M12 is contingent on a type III capsule.
In Chapter 3, I focus on additional ExPEC-like virulence factors that were identified in
Chapter 2, including the zinc acquisition system ZnuABC as well as the type III capsule. For the
first time, the possibility that MAEC strains might cause other ExPEC-associated disease is
explored. Full virulence of strain M12 in mouse models of urinary tract infection and sepsis is
dependent on its capsule. Surprisingly, capsule production is downregulated in the presence of
bile salts and impacts the ability to acquire zinc.
In Chapter 4, I report the sequencing of an additional 94 MAEC strains isolated from
mild or severe clinical cases of mastitis. This allowed the implementation of genome-wide
association studies to determine whether E.coli genes associated with different mastitis clinical
disease outcomes mirror those associated with fitness in experimental models. Putative genes
associated with severe clinical mastitis and genes associated with fitness in bovine and murine
models have been identified through these approaches. These lay the groundwork for additional

18

mechanistic studies to better understand host-pathogen interactions within lactating mammary
glands. The findings of this dissertation highlight important attributes of MAEC strains, their
potential to colonize other tissue sites, and further the understanding of the ExPEC field.
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Chapter 2 Genome-wide identification of fitness factors in mastitis-associated Escherichia coli
Michael A. Olson, Timothy W. Siebach, Joel S. Griffitts, Eric Wilson, David L. Erickson
Applied and Environmental Microbiology Jan 2018, 84 (2) e02190-17
I hereby confirm that the use of this article is compliant with all publishing agreements
2.1 Abstract
Virulence factors of mammary pathogenic Escherichia coli (MPEC) have not been
identified, and it is not known how bacterial gene content influences severity of mastitis. Here,
we report the first genome-wide identification of genes that contribute to fitness of MPEC in
conditions relevant to the natural history of the disease. A highly virulent clinical isolate (M12)
was identified that killed Galleria mellonella at low infectious doses and which replicated to
high numbers in mouse mammary glands and spread to spleens. Genome sequencing was
combined with transposon insertion site sequencing to identify MPEC genes that contribute to
growth in unpasteurized whole milk, as well as during G. mellonella and mouse mastitis
infections. These analyses show that strain M12 possesses a unique genomic island encoding a
group III polysaccharide capsule that greatly enhances virulence in G. mellonella. Several genes
appear critical for MPEC survival in both G. mellonella and in mice, including nutrient
scavenging systems and resistance to cellular stress. Insertions in the ferric dicitrate receptor
gene fecA caused significant fitness defects in all conditions (milk, G. mellonella and in mice).
This gene was highly expressed during growth in milk. Targeted deletion of fecA from strain
M12 caused attenuation in G. mellonella larvae, and reduced growth in unpasteurized cow’s milk
and lactating mouse mammary glands. Our results confirm that iron scavenging by the ferric
dicitrate receptor, which is strongly associated with MPEC strains, is required for MPEC growth
and may influence disease severity in mastitis infections.
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2.2 Importance
Mastitis caused by E. coli inflicts substantial burdens on the health and productivity of
dairy animals. Strains causing mastitis may express genes that distinguish them from other E.
coli and promote infection of mammary glands, but these have not been identified. Using a
highly virulent strain, we employed genome-wide mutagenesis and sequencing to discover genes
that contribute to mastitis. This extensive data set is the first screen for mastitis-associated E. coli
fitness factors and provides the following contributions to the field: 1) Global comparison of
genes required for different aspects of mastitis infection, 2) Discovery of a unique capsule that
contributes to virulence, 3) Conclusive evidence for the crucial role of iron scavenging systems
in mastitis, particularly the ferric dicitrate transport system. Similar approaches applied to other
mastitis-associated strains will uncover conserved targets for prevention or treatment, and
provide a better understanding of their relationship to other E. coli pathogens.
2.3 Introduction
Escherichia coli is a diverse species, encompassing a wide variety of strains that originate
through frequent genetic exchange. While many E. coli strains are commensals that form part of
the normal intestinal flora, there are several pathotypes that cause intestinal or extra-intestinal
illness. Extra-intestinal pathogenic E. coli (ExPEC) include strains that cause urinary tract
infections, neonatal meningitis, pneumonia, and sepsis in humans, strains that cause airway
infections and septicemia in birds, and strains that infect mammary glands and cause mastitis in
lactating mammals. Of these, we understand the least about mastitis-associated E. coli, despite
it’s critical impact on the dairy industry, where it causes annual losses totaling nearly $2 billion
and endangers animal health [152,153].
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A mammary pathogenic E. coli (MPEC) pathotype has been proposed [154], but the
defining characteristics of this group have not been identified. While virulence genes have been
functionally associated with the intestinal E. coli pathotypes (eg. shiga toxin, translocated intimin
receptor, etc.), we lack a similar understanding of the basis for virulence in the unique
environment of the lactating mammary gland despite many years of investigation [155-161].
This has led to the conclusion that strains causing mastitis do not have specific virulence factors,
and it is merely their introduction into the mammary gland and the subsequent inflammatory
response that results in mastitis symptoms [156,161,162]. In this model, disease severity is
primarily dependent on host factors. However, it is unlikely that E. coli strains causing mastitis
are random since not all E. coli are pathogenic in experimental models of the disease [163].
Additionally, mastitis-associated strains are less genotypically diverse than environmental
strains, indicating selective pressure for specific virulence or fitness factors. Nevertheless,
several recent genome comparison studies have failed to consistently identify genes present more
often in strains associated with mastitis than in non-pathogenic strains [27,164-167], and
functional genomic studies aimed at identifying genes required by MPEC to colonize the
mammary gland have not been reported.
In order to cause mastitis, bacteria must gain access through the teat canal and overcome
the immune defenses constitutively present in the mammary gland. The mammary gland is a
transiently mucosal tissue, only producing mucosal secretions during lactation. Mammary gland
epithelial cells secrete numerous soluble antimicrobial defenses to impede bacterial growth, and
these are amplified by an influx of inflammatory cells during infection. Milk contains
components of innate immunity such as antimicrobial peptides, lysozyme, lactoferrin, and
complement. Milk also provides a unique nutritional environment for bacteria, being high in fats
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and sugars with limited availability of free amino acids and iron [168-170]. Shortly after
infection, bacteria are usually eliminated by the inflammatory response that follows, resulting in
transient mastitis. However, some MPEC strains cause severe, acute disease resulting in
permanent mammary gland dysfunction, sepsis or death. Other strains may cause persistent
subclinical infection. MPEC strains that cause transient or persistent mastitis may have distinct in
vitro phenotypes such as motility, suggesting that subtypes defined by carriage or differential
expression of specific genes may exist [171,172]. It is also possible that some MPEC strains
could cause disease in other tissues, but as yet the genes associated with virulence in multiple
hosts or colonization sites are unknown.
We hypothesize that, in addition to differences in host immune factors, variability in the
colonizing strains plays a significant role in determining the severity or nature of the mastitis that
develops in individual cases. Targeted interference of bacterial virulence factors as well as a
better understanding of the most effective host defenses could lead to improved treatment
options. However, we currently do not know enough about MPEC virulence factors to develop
these approaches in an informed way. There is clearly a need for an unbiased, broad-scale
approach to identify genes required by MPEC for colonization and dissemination. In this study,
we demonstrated the utility of the lepidopteran host Galleria mellonella for predicting MPEC
virulence. G. mellonella has been used to measure virulence of several bacterial and fungal
pathogens [173-175]. We then used massively parallel transposon insertion sequencing (Tn-seq)
[176-178] to identify genes that allow MPEC to survive in whole unpasteurized milk, in G.
mellonella, and in murine mammary glands and spleens. We confirmed the relevance of the Tnseq data through targeted deletion mutations. Our results reveal a large number of genes
important for MPEC survival in these distinct conditions. We confirmed the essential role of the
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MPEC ferric dicitrate transport system in obtaining iron and counteracting host nutritional
immunity.
2.4 Results
2.4.1 Virulence of MPEC isolates in Galleria mellonella is predictive of mammary gland
infectivity
G. mellonella has been used previously to measure infectivity of ExPEC clinical isolates
[173,174]. To determine whether these insects would be applicable to studying MPEC
pathogenesis, we screened 20 MPEC strains that were isolated from clinical cases of bovine
mastitis for their ability to kill G. mellonella. The MPEC strains, which were primarily of
phylogroup A, exhibited a broad range of virulence in these assays (Table 2.1). The most virulent
strain (M12) killed all the larvae at the lowest inoculum (103 cfu). In subsequent experiments
with lower infectious doses, we determined that the LD50 for this strain is between 500-1000
CFU. Conversely, none of the larvae were killed by several of the strains (such as isolate M6)
even at the highest dose (105 CFU). Additional infections with less virulent isolates showed that
both M6 and M11 were able to kill some of the larvae at later time points but were still
attenuated in virulence when compared to strain M12 (Fig. 2.1A).
We next sought to determine if the results of the G. mellonella infection assay were
predictive of the virulence of MPEC in mammary gland infections. Because of the sharp contrast
in their virulence in G. mellonella, strains M6 and M12 were selected and injected into the
mammary glands of lactating mice. The M12 strain grew to significantly higher numbers in
mammary glands than strain M6. In addition, strain M12 spread and replicated in the spleens
whereas M6 did not (Fig. 2.1B). These results show that the G. mellonella infection assay is
capable of predicting the virulence potential of MPEC strains in a mouse model of mastitis. It
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might also be used to identify virulence factors relevant to mastitis or disease in other host
environments
Table 2.1 Mortality* of G. mellonella larvae infected with MPEC strains.
Inoculum Size (CFU)
Phylogroup State Isolated
103
104
105
M1
10
0
0
A
NY
M5
0
0
20
A
NY
M6
0
0
0
A
NY
M7
10
20
50
A
NY
M8
0
0
30
A
NY
M9
0
0
10
A
NY
M10
10
10
10
A
NY
M11
20
40
100
A
OH
M13
10
50
90
A
MA
M14
50
50
90
A
NY
M15
70
100
100
A
PA
M16
60
90
100
A
Unknown
M17
60
70
100
A
MD
M18
90
90
100
A
PA
M19
20
80
100
A
OH
M3
30
30
100
B1
NY
M4
10
40
90
B2
NY
M20
70
90
100
B2
NH
M2
20
40
100
D
NY
M12
100
100
100
D
WV
* Percentage of dead larvae determined 24 hours after infection (n=10). Virulence for each strain
was classified as low (green), moderate (orange) or red (high). Highly virulent strains killed
>50% of larvae at the lowest infectious dose. Moderately virulent strains killed >50% of larvae
at highest dose.
MPEC Strain
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Figure 2.1 Virulence of MPEC strains in G. mellonella predicts virulence potential in a mouse
mastitis model.
A) G. mellonella larvae were infected with 103 CFU of MPEC strains M6, M11, M12, and the
control strain E. coli DH5α. Mortality of infected larvae was determined over a 72-h period. M12
virulence was significantly greater than that of the MPEC strains M6 (P < 0.0001) and M11 (P =
0.0003) (log rank [Mantel-Cox] test). (B) Infection of mouse mammary glands (MG) with strains
M6 and M12. Bacteria (250 CFU) were inoculated directly into the teat canal of lactating mice.
After 24 h, strain M12 grew to significantly higher numbers in the mammary glands (*, P =
0.029, by Mann-Whitney test) than strain M6. Strain M12 also colonized the spleens of the
infected mice whereas strain M6 was not detected.
2.4.2 Genome sequencing and annotation of MPEC strain M12
The ability of M12 to infect G. mellonella and grow to high numbers in mouse mammary
glands and disseminate to the spleen suggested that this strain would be particularly useful in
discovering genes that are needed for multiple aspects of MPEC infection. We therefore
sequenced and partially assembled the genome of strain M12. Annotation of the assembled
sequence revealed that, in common with most other MPEC isolates, M12 possesses genes for
Type VI secretion systems, long polar fimbriae, and iron scavenging [27,164,167,179]. Unlike
most MPEC strains, M12 belongs to phylogroup D and to the multi-locus sequence type 69
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complex. Some ST69 strains have been associated with fecal contamination of surface waters
and with human ExPEC infections [180]. They have also been isolated from cattle and their
attendants, and have shown enhanced ability to colonize, persist, and adapt to different hosts
[173,181-183].
2.4.3 Genome-wide identification of genes required for MPEC growth in milk, G.
mellonella, and mice.
We sought to make a comprehensive comparison of genes required for M12 growth in
unpasteurized cow’s milk, G. mellonella larvae, mouse mammary glands and spleens. A Tn-seq
approach was used to measure the contribution of each gene to the relative fitness in these
environments. A library consisting of ~400,000 unique M12 transposon insertion mutants
derived from 40 independently derived pools was created and passaged through the four
experimental conditions (milk, G. mellonella larvae, and mouse mammary glands and spleens;
see Materials and Methods) followed by recovery in LB broth cultures. The mutant populations
were then collected and sequenced in parallel with the control population.
Between 17.8-34.8 million reads were generated for each sample, with 88.8-93.7% of the
reads mapping to single locations in the M12 genome. In total, there were 89,747 unique
insertion sites which were detected across the different conditions, which corresponded to an
average density ranging from 70-158 nucleotides between transposon insertion sites in the
libraries. The transposon insertion sites were then tabulated for each condition (Dataset S1 in
Supporting Information can be retrieved from [17]). Reproducibility between the replicate
samples for each condition was very high, with R2 values between 0.90-0.98 (Supplemental Fig.
S.1).
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To identify genes that may contribute to the fitness of M12 in each of the conditions,
input (LB) and output libraries were compared using the DESeq package [184,185]. Genes that
had a log2 fitness score of -2 or lower (i.e. at least a four-fold reduction in the insertions of the
input:output ratio) and a P value of .05 or lower were identified as candidate genes (Dataset S1
in Supporting Information can be retrieved from [17]). We compared the candidate fitness genes
for each of the test conditions according to their functional categories (Fig. 2.2). The 25 genes
wherein insertions caused the greatest decreases in fitness in each of the four conditions is listed
in Supplemental Table S.1.
It appears that there is a general consistency in the proportions of genes that fall within
each functional category (with some exceptions discussed below), but the individual genes
within the categories varied. However, fewer genes are required for growth in milk than the in
vivo conditions (Fig. 2.2). The nucleotide and amino acid biosynthesis categories contained a
large proportion of the putative fitness genes (Fig. 2.2) and were prominent among those with the
greatest effects on fitness (Supplemental Table S.1). Many of those required for growth in milk
or in mice are predicted to be involved in purine metabolism and the biosynthesis of
phenylalanine, histidine, and serine. Genes involved in nucleotide metabolism have previously
been shown to be required for E. coli growth in blood and spleens [186,187]. Our results indicate
they are also required for growth in milk, further indication that de novo synthesis pathways are
crucial virulence factors in mammals.
The virulence, disease and defense category represented a larger proportion of the total
genes in in vivo conditions than in milk (Fig. 2.2). These genes primarily encode membrane
transport functions, including metal resistance and efflux genes and are listed in Supplemental
Table S.2. Genes required for resistance to cellular stresses were also prominent, especially in
the in vivo
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conditions. M12, like other E. coli strains, encodes three superoxide dismutase (SOD) enzymes
that utilize different metals as co-factors. The sodA (encoding Mn-SOD), sodB (Fe-SOD), and
sodC (Cu/Zn-SOD) genes were each predicted to enhance M12 fitness in G. mellonella
(Supplemental Fig. S.2). Besides SOD enzymes, the Dps protein helps bacteria survive oxidative
stress by binding to DNA and iron to prevent damage from iron-catalyzed Fenton reactions
[188]. Insertions in the dps gene reduced M12 fitness in each of the in vivo conditions but not in
milk (Supplemental Fig. S.2). The HtrA-family protein DegP removes misfolded periplasmic
proteins during oxidative or heat stress [189], and has been shown to be required for E. coli
survival during mouse bladder infections [190]. DegP is activated by the sigma factor RpoE,
which our Tn-seq data indicates is essential for viability in M12. RpoE is repressed by the antisigma factor RseA [191]. The degP and rseA genes also appeared to be required by M12 in the
in vivo environments but not in milk.
In addition to oxidative stress resistance, the transcriptional regulatory protein NsrR and
the nitric oxide reductase flavorubredoxins are required for E. coli responses to nitric oxide
[192]. Insertions in the nsrR gene reduced M12 fitness in mice and G. mellonella, and insertions
in the norV gene reduced fitness in mice but not in G. mellonella (Supplemental Fig. S.2). The
requirement for several oxidative and nitrosative stress resistance genes particularly in vivo but
not in whole milk may be attributed to the initiation of inflammatory responses. Influx of
neutrophils or hemocytes, activation of prophenyloxidase or degranulation cascades,
upregulation of the oxidative or nitric oxide burst occur only in the presence of living phagocytic
cells, and thus bacterial defense mechanisms are most critical in these conditions. Many of these
genes are known to be virulence factors for ExPEC in other environments, and these results
suggest they may also be important for MPEC mastitis.
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Figure 2.2 Functional classification of genes required for M12 fitness in milk, G. mellonella,
and mouse mammary glands and spleens.
Genes with a log2 fitness score of −2 or lower (i.e., at least a 4-fold reduction in insertions in the
output pool relative to the input pool) and a P value of 0.05 or lower were identified as candidate
genes and grouped according to their annotated function.
2.4.4 Genes encoding a type III polysaccharide capsule are required for virulence in G.
mellonella.
We were interested in identifying genes encoding bacterial surface structures that have
direct interaction with host cells or surveillance proteins. One cluster of genes which appeared to
contribute significantly to fitness only in G. mellonella was predicted to encode synthesis and
transport of a polysaccharide capsule (Fig. 2.3A). Examination of the assembled M12 contigs
showed that these genes are found on a putative genomic island in M12 not previously associated
with MPEC strains. Within the 33 kb island are kpsS, kpsC, and kpsDEMT genes ordered
according to group III capsule synthesis and export systems [193]. The island also contains
nucleotide sugar biosynthesis, glycosyltransferase, and modification genes in this region in an
arrangement that does not appear in any other publicly available bacterial genome sequence,
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suggesting lateral gene transfer and/or extensive recombination, possibly resulting in a novel
capsule type.
The Tn-seq data indicated that the capsule genes were particularly important for G.
mellonella infection, but were detrimental to fitness during colonization of mouse mammary
glands (Fig. 2.3B). To confirm the validity of these Tn-seq results, the contribution of this
putative capsule to survival in G. mellonella and mouse mastitis was assessed. A mutant strain
with a deletion of the kpsCS genes predicted to be necessary for initiation of capsule synthesis
was generated [74]. The production of capsule in the wild type M12 bacteria was examined using
SDS-PAGE and Alcian blue staining (Fig. 2.3C). In contrast to the abundant capsule produced
by the wild type strain, as expected, the mutant strain failed to produce detectable capsule and
replacement of the kpsCS genes on a multi-copy plasmid partially restored capsule production. In
G. mellonella infections, the ∆kpsCS mutant strain was much less virulent than the wild type
strain (Fig. 2.3D), consistent with the Tn-seq result. Complementation restored virulence to
nearly wild-type levels, correlating with capsule production. Fitness of the ∆kpsCS mutant during
mouse mammary gland infections was then tested in competition assays with the wild type
strain. Unlike the Tn-seq results which predicted that the mutant would have enhanced fitness,
the ∆kpsCS mutant had a slight but statistically significant decrease in survival after a 24-hour
infection in the mammary glands of mice (Fig. 2.3E).
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Figure 2.3 A unique genomic island in MPEC strain M12 encodes a type III capsule that
contributes to virulence.
(A) Genetic organization of the 33-kb island containing capsule biosynthesis genes, including
kpsS and kpsC which were deleted in the ΔkpsCS mutant strain. (B) Tn-seq determination of
fitness costs (log2 fitness score) associated with disruptions to M12 kpsC and kpsS genes in milk,
G. mellonella, or during mouse infections (***, P < 0.001). (C) Gel electrophoresis and Alcian
blue staining of capsular material shows that the mutant strain fails to produce capsule that is
detectable in the wild-type strain and complement (pMO1). (D) The ΔkpsCS mutant strain is
avirulent in G. mellonella, with no lethality evident in larvae injected with up to 30,000 bacteria
in contrast to complete killing by the wild-type and complemented strains (**, P = 0.0043; ****,
P < 0.0001, by log rank test). (E) Competition between the M12 wild-type strain and ΔkpsCS
mutant (500 CFU) was measured during mammary gland infection in lactating mice. After 24 h,
mice were sacrificed, and the competition index (means ± standard errors of the means) was
determined (*, P = 0.0002, by one-sample t test). ns, not significant.
2.4.5 Nutrient scavenging genes
The genome sequence of strain M12 and the Tn-seq results together suggest a critical role
for nutrient scavenging in mastitis pathogenesis. M12 encodes multiple iron acquisition systems,
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including receptors for the enterobactin (fepA) and yersiniabactin (fyuA) siderophores. It also
encodes the sitABCD and mntH uptake systems for iron and manganese, as well as the high
affinity zinc uptake transport system (znuABC). The Tn-seq results indicate that genes encoding
the enterobactin receptor and uptake system are necessary for bacterial growth in G. mellonella
and in spleens (Fig. 2.4A). While other siderophores have been previously shown to contribute to
ExPEC virulence, a role for enterobactin has not been identified [194]. Conversely, the
yersiniabactin receptor genes do not appear important for survival in G. mellonella or in
mammary glands, but do appear to be important for survival in spleens (Fig. 2.4A). The transport
systems for zinc (znuABC) and iron/manganese (sitABCD) also appear to be required for fitness
in G. mellonella and in mice (Fig. 2.4A).
Transposon insertions in the fecA gene also resulted in significantly less growth in milk,
G. mellonella, and mouse mammary glands (Fig. 2.4A). The fecABCDE operon encodes an
uptake transport system for ferric dicitrate [195]. This chelated form of iron effectively reduces
the iron availability in environments such as milk and insect hemolymph. Thus, citrate can be
considered an iron sequestration factor that may prevent bacterial growth in these environments
[196-198]. The ferric dicitrate receptor FecA, along with its accessory proteins FecB and FecC,
enable bacteria to transfer ferric dicitrate across the outer membrane and incorporate essential
iron [199,200]. Insertions in the fecA, fecB, and fecC structural genes, as well as the sigma factor
fecI which activates transcription of the operon in response to ferric dicitrate, decreased fitness in
milk and the in vivo conditions.
The requirement for iron scavenging systems for growth in milk indicates the iron-limited
nature of this environment. To further investigate which of the iron acquisition systems might be
important for growth, we measured expression of four iron scavenging genes following transfer
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of actively growing M12 culture into whole unpasteurized cow’s milk (Fig. 2.4B). These genes
are all known to be regulated by the availability of iron at least partially through the ferric uptake
regulator protein Fur [201-204]. Three of four genes (fecA, fepA, and sitA) were strongly
upregulated 1 h after transfer to cow’s milk. These results confirm that iron availability is
severely limited in milk, likely as a consequence of its sequestration by lactoferrin and citrate
and that the ferric dicitrate system is especially highly expressed.

Figure 2.4 Nutrient-scavenging genes are required for fitness in G. mellonella, mice, and growth
in milk and are highly expressed during growth in milk.
(A) Fitness costs (log2 fitness score) associated with disruptions to M12 nutrient-scavenging
genes in milk, G. mellonella, or during mouse infections as measured by Tn-seq (*, P < 0.05; **,
P < 0.01; ***, P < 0.001). (B) The change in transcription levels of iron receptors fecA, fepA,
fhuE, and sitA was determined 4 h after transfer to whole unpasteurized milk. The change in gene
expression levels was determined relative to that of control cultures in LB medium (*, P =
0.0273; **, P = 0.0092; ***, P = 0.0019, by one-sample t test).
2.4.6 Ferric dicitrate transporter (fecA) enhances M12 growth and virulence
Previous genome sequencing and PCR-based screens of MPEC strains have found that
these strains are more likely than other pathotypes to carry genes for type VI secretion systems,
long polar fimbriae, and the ferric dicitrate uptake system (fecABCDE). According to our Tn-seq
results, the Type VI secretion system and long polar fimbriae are not required for fitness in any
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of the experimental conditions. The Tn-seq data indicated a strong fitness defect when the fecA
operon is disrupted (Fig. 2.4A), and the fecA gene is highly upregulated during growth in milk
(Fig. 2.4B), which suggested an important role for this system.
To verify the role of the ferric dicitrate iron scavenging system in overcoming iron
limitation, we created a deletion mutant of the outer membrane receptor fecA gene in strain M12.
Compared to the wild type strain, the ∆fecA mutant grew significantly less well in bovine or
mouse milk in single culture experiments (Fig. 2.5A). The growth defect of the mutant strain was
much more pronounced during growth in cow’s milk than in the mouse milk, which may be due
to the higher abundance of citrate in cow’s milk [166,205,206]. We then complemented the
mutation by replacing the fecABCDE genes on a multi-copy plasmid and tested the fitness of the
mutant and complemented strains in 1:1 competition assays with the wild type strain in cow’s
milk (Fig. 2.5B). The mutant had an approximately 3-log reduction in fitness, and the
competitive fitness was restored to wild type levels in the complemented strain.
We then tested the virulence of the ∆fecA mutant in G. mellonella and in mouse mastitis
infections. The mutant was severely attenuated in the larva when compared to the wild-type
strain over a range of inoculum concentrations (500-50,000 CFU) (Fig 2-5C). The virulence of
the mutant was restored by complementation with the fecABCDE plasmid. In mouse mammary
gland infections, numbers of the mutant strain bacteria were 10 to 100-fold lower than the wildtype strain after 24 hours after infection (Fig. 2.5D).
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Figure 2.5 The fecA gene is required for optimal M12 growth in whole milk and for virulence in
G. mellonella and in murine mammary glands.
(A) Growth of the M12 wild-type or ΔfecA mutant strain was measured in whole unpasteurized
milk (cow or mouse) after 4 h. The mutant strain had significantly decreased growth in both cow
and mouse milk (*, P = 0.033; **, P = 0.0046, by Student's t test). (B) Competitive fitness of the
M12 wild-type strain, ΔfecA mutant, or complemented (pMO2) strain was determined by
competition assays in cow's milk. The mutant strain was significantly less fit (*, P < 0.0001, by
one-sample t test) than the wild-type strain whereas the complemented strain was not. (C)
Virulence of M12 wild-type or ΔfecA mutant bacteria measured in G. mellonella infections.
Groups of larvae were infected with the indicated number of bacteria, and survival was measured
24 h after infection. The ΔfecA mutant strain was significantly less virulent in the larvae (**, P <
0.01; ***, P < 0.001, by log rank test). (D) Virulence of M12 wild-type or ΔfecA mutant bacteria
during mouse infections. Lactating mice were infected with ∼300 CFU of either the wild-type or
ΔfecA mutant strain, and bacterial numbers in mammary glands or spleens were determined after
24 h. Growth of the mutant strain was significantly different from that of the wild type in
mammary glands (**, P = 0.0022, by Mann-Whitney test) but not in spleens. (E) Competitive
fitness levels of the ΔfecA mutant strain were compared during infection of lactating and
nonlactating mice. Mice were infected with mixtures of mutant and wild-type M12 strains, and
bacterial growth in the mammary glands was measured after 24 h. The fitness of the ΔfecA
mutant strain was significantly lower during infection of lactating mice (*, P < 0.0001, by one
sample t test) but not in nonlactating mice. ns, not significant.
However, the mutant and wild type strains achieved similar concentrations in the spleens
of the infected mice. This suggested that the ∆fecA mutation prevents the acquisition of iron from
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citrate complexes in milk but does not impact iron acquisition from other sources. To more fully
test this hypothesis, we compared the fitness of the ∆fecA mutant strain in competition with the
wild-type strain in lactating and in non-lactating mouse mammary glands (Fig. 2.5E). As with
the single infection experiments, the mutant was less fit in lactating mice in the competition
experiments. In contrast, the growth of the mutant strain was not significantly different from the
wild type during infection of non-lactating mice. Therefore, in environments where citrate is
present (in vitro in milk, lactating mouse mammary glands and insect hemolymph), fecA enables
significantly more bacterial growth but is dispensable in environments where citrate is not
present (non-lactating mammary glands and spleens).
2.5 Discussion
In this study, we utilized Tn-seq to identify genes required by MPEC in environments
that are relevant to its natural history, including growth in milk, exposure to an effective innate
immune system, and colonization of mammary tissues. We showed that a G. mellonella larvae
model was able to discriminate between strains with high and low virulence potential in
mammary glands, providing a relevant, convenient method to investigate the molecular
pathogenesis of MPEC strains. The variability in virulence towards G. mellonella among this
relatively small set of MPEC strains was unexpectedly high, as mastitis-associated E. coli are
commonly perceived as generic inducers of inflammation. Most previous studies investigating
the nature of mastitis-associated strains conclude that they are commensals belonging mainly to
phylogroups A and B1 [156,160]. They are thought to possess few, if any, known virulence
factors that would be predicted to influence the severity of disease in mammary glands, or allow
them to cause disease in other contexts [161,162]. Our results challenge this interpretation.
Instead, they support the idea that some mastitis-associated strains may share features in
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common with other phenotypic groups of E. coli, and that more detailed studies are required to
elucidate virulence genes that may be strain-specific [207]. This is reminiscent of other recent
findings where strains classified as non-pathogenic have been isolated from the bloodstream of
immunocompromised patients [208], and intestinal pathogenic O157:H7 strains have been
recovered from urinary tract infections [209]. It is possible that the variation among MPEC
strains in their ability to infect and kill G. mellonella correlates with virulence in mammary gland
infections only. Alternatively, it may reflect a previously unappreciated ability of some mastitisassociated strains to cause disease in other contexts, which is deserving of further investigation.
Similar to milk, G. mellonella hemolymph contains iron-sequestering proteins and citrate
that severely limit iron from invading pathogens [196,210]. It also contains lysozyme and
antimicrobial peptides that inhibit or kill bacteria [211]. Their hemocytes phagocytize and kill
bacteria in a similar fashion as neutrophils [212]. They also activate a proteolytic phenoloxidase
cascade functionally similar to complement at the surface of bacteria, leading to engulfment and
deposition of toxic reactive oxygen molecules [213]. It is not surprising, then, that a large
number of genes important for survival in mouse mammary glands were also required in G.
mellonella, including stress resistance and detoxification as well as nutrient acquisition
functions. For instance, the inner-membrane zinc uptake genes znuABC, which are also required
for Acinetobacter baumanii virulence in G. mellonella [214], appear important for M12 survival
in mice and G. mellonella. High-affinity transport by bacteria can combat the effects of the zinc
and manganese chelating protein calprotectin, which is abundant in neutrophils and released as a
component of extracellular traps [124,141,215]. Neutrophil influx, degranulation, and
extracellular trap formation are early critical events in the mammary gland immune response to
mastitis [216,217], and mammary epithelial cells may also release calprotectin [218]. Zinc and
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manganese are cofactors for the superoxide dismutases sodA and sodC, which our data suggest
are required for MPEC virulence. Additional experiments need to be carried out to determine if
G. mellonella has a calprotectin-like protein as well as the role of znuABC in dealing with
oxidative stress in the context of mammary gland infections.
The mastitis-associated strain M12 was particularly virulent in the G. mellonella model
and grew prolifically in mouse mammary glands. We found that a significant portion of its
virulence in G. mellonella can be attributed to production of a type III capsule encoded on a
genomic island. A mutant unable to produce capsule was avirulent in the larvae and slightly
attenuated in mouse mammary gland infections. Some group II or III capsules have been shown
to contribute to urinary tract or bloodstream ExPEC survival [219-222]. However, capsule
production has not been previously shown to affect virulence of E. coli in mastitis.
Microscopically visible production of capsule material by mastitis isolates has been observed
[223], but phage or PCR-based screens for capsule genes has generally shown only sporadic
carriage by mastitis-associated strains [157,160,165]. Capsule production could provide a slight
advantage to strain M12 in the mammary gland by masking bacterial-associated molecular
patterns and delaying initial detection, enhancing complement resistance, or providing protection
against neutrophils and macrophages. The much larger reduction in fitness of the ∆kpsCS mutant
in the G. mellonella infections suggests that there may be environments outside the mammary
gland where this group III capsule confers a more significant advantage. The reason for the
dramatically reduced virulence of the mutant during G. mellonella infections requires further
investigation, but it suggests that this capsule may have a more prominent role in enhancing
survival of the bacteria in their intestinal reservoir or during infections in other extraintestinal
niches [207].
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Our study confirms the role of the ferric dicitrate transport system encoded by the fecA
operon, at least for one mastitis-associated E. coli strain. The fecA gene has been one of very few
that consistently appears in screens of MPEC strains, which has led to speculation that it confers
a key advantage for growth in mammary glands. Based on its antigenic consistency among
mastitis-causing strains, Lin et al. proposed vaccinating cattle with recombinant FecA protein in
order to elicit anti-FecA antibodies that could limit bacterial growth [205]. However, they found
that vaccinated cattle produced antibody that was insufficient to affect bacterial growth in
mammary glands of the vaccinated animals [224]. It is unclear whether the antibodies in their
study were able to completely block FecA function, or if the bacteria were able to acquire iron
via other methods [225]. Our Tn-seq data suggest that the ferric dicitrate and enterobactin
siderophore iron acquisition systems are non-redundant, at least for the M12 strain in mouse
mammary gland infections.
Our results clearly demonstrate that a mutation eliminating FecA function has a strong
detrimental effect on bacterial replication in environments that contain citrate, including cow’s
milk and mouse mammary glands. Citrate is an iron chelator, and bacteria with the ability to
utilize this iron source have a growth advantage. In addition to ferric dicitrate, ferric-lactoferrin
is the other major iron source potentially available to bacteria in milk. Siderophores such as
enterobactin or yersiniabactin could remove iron from lactoferrin, enabling bacterial acquisition
through ferric-siderophore receptors. However, production of siderophores is an energetically
expensive process and is susceptible to interference by other bacteria. Therefore, strains may
achieve faster growth by fecA-mediated iron acquisition than by siderophore-mediated
acquisition. Levels of citrate and lactoferrin in the milk of dairy cattle vary depending on the
time of lactation [198]. Citrate levels are highest relative to lactoferrin early in lactation, a time at
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which cattle are most susceptible to severe mastitis. Later in lactation the levels of citrate fall,
and typically mastitis is less severe. It is possible that utilization of ferric citrate as an iron source
contributes to the propensity for severe mastitis early in lactation, but the increased energy costs
associated with using lactoferrin reduce bacterial growth rates later in the lactation cycle, tipping
the balance towards resolution of infection and milder disease.
While the majority of mastitis-associated strains may be more fit in the mammary gland
environment because they express FecA, it is clearly not a universal requirement. Substantial
variation exists among ExPEC isolates even within the same niche, and the emergence of
tropism for mammary glands has likely evolved among many separate lineages. Epidemiological
and experimental approaches aimed at identifying genes that explain the properties of MPEC are
unlikely to identify any single ubiquitous locus [165]. Rather, like other ExPEC types [226,227],
there may exist a spectrum of overlapping virulence gene requirements. The necessity of any
single gene for survival in mammary glands may depend on the genetic background of the
individual strain. Such variability should be considered in the development of therapeutic
strategies that will be broadly effective in the treatment of E. coli mastitis.
2.6 Materials and methods
2.6.1 Bacterial strains and growth conditions
E. coli strains (Table 2.1) were generously supplied by Paolo Moroni (Cornell University
Animal Health Diagnostic Center, Ithaca, NY). They were isolated from individual quarter milk
samples from cattle with clinical mastitis. Putative E. coli were identified based on colony
morphology on blood and MacConkey agar plates, followed by potassium hydroxide,
cytochrome oxidase, citrate, ornithine decarboxylase, lysine, motility, and indole biochemical
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tests. E. coli strains were routinely grown in Luria-Bertani (LB) media at 37°C. To select for
mutant strains or carriage of plasmids, growth media was supplemented with kanamycin (50
μg/mL), chloramphenicol (10 μg/mL), or ampicillin (100 μg/mL) as appropriate. For milk
cultures, whole, unpasteurized cow’s milk was obtained from a local supplier and used
immediately or stored at -80°C until use. Mouse milk was obtained as described previously
[228], and used immediately after collection.
Phylogroup analysis of the isolated E. coli strains was performed as described by
Clermont et al. [229]. Multiplex PCR products were separated on agarose gels, and carriage of
the genes chuA and yjaA and the DNA fragment TspE4 were determined. Primer sequences used
in this study are given in Table 2.2.
Table 2.2 Plamsids and primer sequences used in this study
Primer
Name
TspE4C2.2
TspE4C2.1
YjaA.2
YjaA.1
ChuA.2
ChuA.1
50 bp fecA
Cm Forward
50 bp fecA
Cm Reverse

Primer Sequence 5’-3’

Purpose

CGCGCCAACAAAGTATTACG
GAGTAATGTCGGGGCATTCA
TGGAGAATGCGTTCCTCAAC
TGAAGTGTCAGGAGACGCTG
TGCCGCCAGTACCAAAGACA
GACGAACCAACGGTCAGGAT
TTCTCGTTCGACTCATAGCTGAACACAACAAAA
ATGATGATGGGGAAGGTGTTGATCGGCACGTAA
GAGG
CAACATAATCACATTCCAGCTAAAAGCCCGGCA
AGCCGGGCGTTAACACAAAAATTACGCCCCGCC
CTG
ATGACGCCGTTACGCGTTTT

phylogroup analysis

fecA
Complement
Forward
fecA
TCAGAACTTCAACGACCCCT
Complement
Reverse
Kps KO and GTTCACAGAGACAACATGTATTTATATACGGGA
CMR
TCGAAAGGGATTCTTGCCAAAATTACGCCCCGC

knockout of fecA

Complementation of
fecA

knockout of kpsSC
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reverse
(M12)
Kps KO and
CMR
forward
(M12)
Kps comp R
Kps comp F
rssA 3
Forward
rssA 3
Reverse
hcaT 2
Forward
hcaT 2
Reverse
fecA
Forward
fecA
Reverse
fepA
Forward
fepA
Reverse
fhuE
Forward
fhuE
Reverse
sitA
Forward
sitA Reverse
CM Internal
Forward
CM internal
Reverse
1TN

CCTG

1OLIGOG

CAGACGTGTGCTCTTCCGATCggggggggggg

2TNAnn

AATGATACGGCGACCACCGAGATCTACACTCTT
TCCCTACACGACGCTCTTCCGATCTNNNNTCGAG
ATGTGTATAAGAGACAG
AATGATACGGCGACCACCGAGATCTACACTCTT
TCCCTACACGACGCTCTTCCGATCTNNNNnTCGA

2TNBnn

TCGCTGCGGTTGTTGGCTGATTGAGTAACCTGAA
ACGCCCATGAAAACCAGTTGATCGGCACGTAAG
AGG
TTTTGTAACACTGACTGAATCGGC
CACATTCTGGCTGTACGAAAAAGT
CGAAGCGACGGGAACAATTT

Complementation of
kpsCS
qPCR - housekeeping
reference gene

GATGGATCTCTCCTGGCAGC
CTTTTCCGCCGTTGTAGTGC
ACCACTATCAACCACGGCAA
GACACCTACGGCAATCTGGTA

qPCR - target gene

CTGGACTGGAAATCGCTGTTC
CTACAGTAAAGGTCAGGGCTG
CAAGGAGATTGGTCTGGAGTTC
ATAGAGGTATAGCTGGCGTAGG
GTAAGTCAGCGTATCAACCCG
CATATCCCGGCAGTCTTTAGC
GCTCTATGTCGATTCCCTGAG
GAAAGACGGTGAGCTGGTGA
GCCACTCATCGCAGTACTGT
CTGACCCGGTCGAC

amplification of
chloramphenicol
resistance for
knockout strains
binds slightly back
from the transposon
end
binds the C-tail, adds
part of the index
primer binding site
Adds Illumina
adapter and Ns bases
are inserted
depending on the
sample. This ensures
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2TNCnn
2TNDnn
BAR01
BAR02
BAR03
BAR04
BAR05
BAR06
BAR07
BAR08
BAR09
BAR10
Plasmid
pRE12

GATGTGTATAAGAGACAG
AATGATACGGCGACCACCGAGATCTACACTCTT
TCCCTACACGACGCTCTTCCGATCTNNNNnnTCG
AGATGTGTATAAGAGACAG
AATGATACGGCGACCACCGAGATCTACACTCTT
TCCCTACACGACGCTCTTCCGATCTNNNNnnnTCG
AGATGTGTATAAGAGACAG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
ATCACGATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
CGATGTATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
TTAGGCATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
GCCAATATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
ACAGTGATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
CAGATCATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
TGACCAATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
GATCAGATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
ACTTGAATCTCGTATGCCGTCTTCTGCTTG
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC
CTTGTAATCTCGTATGCCGTCTTCTGCTTG

pMO1

Relevant properties
Source of chloramphenicol resistance gene for creating
knockout strains
Lambda-red recombination plasmid
Cloning vector for creating complemented strains
Tn5 delivery plasmid for creating transposon mutant
libraries
Complementation plasmid containing kpsSC genes

pMO2

Complementation plasmid containing fecABCDE genes

pKD46
pJET1.2
pJG714

that different clusters
on a
multiplexed lane are
reading diverse bases

Adds illumina adapter
and incorporates
barcode to identify
sample on
multiplexed lanes

2.6.2 G. mellonella infections
G. mellonella larvae were purchased from Best Bet, Inc. (Blackduck, MN), stored at
15°C in the dark and used within two weeks. An overnight culture of bacteria was subcultured
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and grown to an absorbance of 1.0 at 600 nm and diluted in phosphate-buffered saline (PBS).
The concentration of each inoculum was determined by serial dilution and colony counting after
24 h growth on LB agar plates. Larvae without any evidence of melanization were selected and
injected with either 102, 103, 104 or 105 CFUs through the left hindmost proleg with 10 µL of the
inoculum using a Hamilton 701RN syringe and a 30-gauge needle. Control larvae were injected
with 10 µL of sterile PBS. The larvae were incubated at 37°C and survival was monitored at the
end of a 12 h period or at intervals over 72 h period.
2.6.3 Ethics statement
Mouse experiments were performed in accordance with the recommendations found in
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The
protocol was reviewed and approved by the Institutional Animal Care and Use Committee of
Brigham Young University (Protocol No. 160302).
2.6.4 Mouse infections
Lactating BALB/c mice between 9-12 weeks of age were used in all experiments.
Lactating mothers 10-11 days post-partum were chosen for all experiments. Mice were infected
based on the method described by Brouillette [230] with slight modifications. Briefly, mice were
anesthetized using 75 -100 μl of a ketamine/xylazine solution. An overnight culture of bacteria
was subcultured and grown to an absorbance of 1.0 at 600 nm and diluted in PBS. The
concentration of each inoculum was determined by serial dilution and colony counting after 24 h
growth on LB agar plates. An inoculum dose of 5*102 CFUs/50 μl suspended in PBS was then
injected directly through the teat canal into the ductal network of the L4 and R4 mammary
glands using a Hamilton model 1705TLL syringe and a 33-gauge needle with a beveled end.
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Pups were removed for 1-2 hours after injections and then were returned. Control glands were
inoculated with 50 µl of sterile PBS in both L4 and R4 glands. Mice were monitored for 24 h and
tissue subsequently harvested. Bacterial load in the mammary gland and spleen was determined
by homogenizing the tissue in 1 mL of PBS, performing serial dilutions and colony counting
after 24 h growth on LB agar plates.
2.6.5 M12 genome sequencing, assembly and annotation
Total DNA from strain M12 was isolated using ZR Fungal/Bacterial DNA MiniPrep™
kit (Zymoresearch). The DNA was sheared and sequenced at the University of Southern
California NextGen Sequencing Core. Illumina paired-end reads of 250 bp were generated on
MiSeq V2 sequencer. Contigs were built from these reads using Velvet short read sequence
assembler [231]. The contigs were then ordered with Mauve using the E. coli K12 sequence as a
reference [232]. The partially assembled genome was annotated using a RAST online automated
annotation service [233,234].
2.6.6 Gene deletions and complementation
Gene deletions of kpsCS and fecA were generated via lambda-red recombination in strain
M12 carrying the plasmid pKD46 [235]. Gene-replacement constructs were created by PCR
using pRE112 as a template to amplify the chloramphenicol resistance gene, cat, with 50 base
pairs of homology to the target genomic sites. Bacteria expressing the recombinase enzymes
were electroporated with 200-500 ng of purified DNA, and potential mutants selected by plating
on LB containing chloramphenicol. Potential mutants were then screened by PCR using primers
flanking the recombination site and also with primers internal to the kpsCS or fecA genes. To
complement the mutations, the fecABCDE or kpsCS genes were PCR amplified and cloned into
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the multi copy plasmid pJET2.1. The resulting plasmids were then used to transform the mutant
strains.
2.6.7 Tn-Seq screens
The experimental workflow for the Tn-seq screens is outlined in Supplemental Fig. S.3.
The M12 mutant library was created by bi-parental mating with the DAP auxotroph E. coli
MFDpir harboring plasmid pJG714, which contains a Tn5 transposon cassette in which the
kanamycin resistance gene points out one side, and the Salmonella Ptrp promoter points out the
other. Donor and recipient bacteria were spotted on LB agar supplemented with DAP for two
hours, after which the mixture was spread onto extra-large plates of LB agar containing
kanamycin (50
μg/mL) without DAP. Separate colonies from forty plates containing 10,000 independent
colonies were then pooled to create a library of strain M12 consisting of ~400,000 unique
transposon insertion mutants. The library was frozen down in 1 mL aliquots of LB broth with
15% glycerol for Tn-Seq screens.
The transposon library was subcultured 1:10 into fresh LB broth and allowed to recover
for one hour before Tn-Seq screens in LB broth, milk, G. mellonella, mammary gland, and
spleens. For in vitro conditions, 4x108 CFUs were inoculated into 100 ml of unpasteurized cow’s
milk or LB broth in duplicates and grown for 12 hours, then diluted 1:10 into fresh LB broth and
grown for an additional eight hours. Bacteria were then harvested and frozen in LB-15%
glycerol. For in vivo conditions 5,000 CFUs were injected into 2,000 larvae, and 106 CFUs
injected into the L4 and R4 mammary gland of 6 mice and incubated for 24 hours. The larvae,
mammary glands, and spleens were harvested, divided equally into biological duplicates and
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homogenized in PBS. The homogenates were inoculated into LB broth containing kanamycin
and grown for 8 hours, harvested and frozen in LB containing 15% glycerol.
2.6.8 DNA preparation and Illumina sequencing
Cells from the input pool (LB) and output pools (milk, larvae, MGs, and spleen) were
pelleted and genomic DNA extracted using a ZR Fungal/Bacterial DNA MiniPrep™ kit
(Zymoresearch). Genomic DNA (150 ng) was digested using dsDNA fragmentase (NEB) for
exactly 12 minutes to create fragments that were between 500 bp to 3,000 bp. Genomic DNA
fragments were isolated and cleaned using QIAprep Spin Miniprep Kit (Qiagen). To facilitate the
PCR amplification of transposon insertion junctions, cytosine was added to the ends of the
fragments using terminal transferase (NEB). C-Tailed transposon junctions were PCR amplified
(Phusion) for 15 cycles, and Illumina adapters with barcodes were added by an additional 20
cycles with an extension time of 20 seconds to generate products between 150-700 bp. The PCR
products were column purified prior to sequencing. Primers used to amplify transposon junction
sites and add Illumina sequencing adapters with barcodes are listed in Table 2.2. The 10 DNA
samples with their unique barcodes were pooled together with the same concentrations based on
measurements from a NanoDrop spectrophotometer (ThemoFisher).
2.6.9 Tn-Seq data anaylsis
Data analysis was performed using TnSeq–Pipeline [236] and consists of mapping the
transposon back to the M12 reference genome using bowtie2, read normalization and the
removal of reads located at the edges of genes to ensure that functional genes are not included in
downstream analyses [237]. Raw count tables for each gene generated by TnSeq-Pipeline were
analyzed by DESeq package in R. The fold change (i.e ratio of input:output read counts) values
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were log2 transformed and a P value was calculated using a negative binomial distribution
performed by DESeq. Candidate genes identified to have a fitness cost in experimental
conditions needed to pass two criteria; a log2 fold change of -2 or less and a P value of .05 or
less. Additionally, genes that were normalized for length that had few or no insertions were
categorized as putative essential genes.
2.6.10 RNA isolation and qPCR
Bacteria were grown overnight in LB and then subcultured to exponential phase (A600 =
1.0). Washed bacterial cells were then transferred to either unpasteurized whole cow or mouse
milk, or into LB broth at a concentration of 108 CFU/ml and incubated for 30 minutes at 37°C.
Milk samples were diluted 5-fold into cold PBS, pelleted and resuspended in cold PBS. The
samples were then diluted 5x in RNAlater (Thermofisher) and stored at -80°C. RNA was isolated
using rBAC Mini Total RNA Kit (IBIscientific) according to manufacturer’s instructions. The
integrity of the isolated RNA was verified by gel electrophoresis. The RNA was used to make
cDNA using ProtoScript® II First Strand cDNA Synthesis Kit (NEB). Quantitative PCR primers
specific for each gene were designed to give 100-150 bp products (Table 2.2). Reactions
consisted of qPCR 2x SybrGreen Master Mix, High ROX (Genesee Scientific) with 3 µM each
of forward and reverse primers and were performed using a StepOne real-time PCR system. The
cycling conditions were as follows: 95°C for 15 min followed by 40 cycles of 95°C for 15
seconds then 60°C for 1 min. A melt curve analysis was performed to confirm the specificity of
the PCR amplification. The resulting Ct values were normalized as described by Vandesompele
et al [238], to the stably-expressed genes rssA and hcaT. The fold change in expression of the
iron genes in milk relative to the LB cultures was determined using the comparative ΔΔCt
values.
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2.6.11 Capsule isolation and staining
Capsule production was visualized as previously described [239]. Briefly, bacteria were
pelleted from 5 ml of saturated overnight cultures grown in LB. The bacterial cells were then
resuspended in 1 ml PBS and heated to 55°C for 1 h. The bacteria were removed by
centrifugation and the supernatants treated with proteinase K for 1 h at 59°C. The samples were
concentrated using 20 kDa MWCO Millipore filters, followed by electrophoresis on 10% SDSpolyacrylamide gels and staining with 0.125% Alcian blue dye in 40% ethanol/5% acetic acid.
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Chapter 3 A link between zinc uptake, bile salts, and a capsule required for virulence of a
mastitis-associated extraintestinal pathogenic Escherichia coli strain
3.1 Abstract
Extraintestinal pathogenic Escherichia coli (ExPEC) are major causes of urinary and
bloodstream infections. ExPEC reservoirs are not completely understood. Some mastitisassociated E. coli (MAEC) strains carry genes associated with ExPEC virulence, including metal
scavenging, immune avoidance, and host attachment functions. In this study, we investigated the
role of the high-affinity zinc uptake (znuABC) system in the MAEC strain M12. Elimination of
znuABC moderately decreased fitness during mouse mammary gland infections. The ΔznuABC
mutant strain exhibited an unexpected growth delay in the presence of bile salts, which was
alleviated by the addition of excess zinc. We isolated ΔznuABC mutant suppressor mutants with
improved growth of in bile salts, several of which no longer produced the K96 capsule made by
strain M12. Addition of bile salts also reduced capsule production by strain M12 and ExPEC
strain CP9, suggesting that capsule synthesis may be detrimental when bile salts are present. To
better understand the role of the capsule, we compared the virulence of mastitis strain M12 with
its unencapsulated ΔkpsCS mutant in two models of ExPEC disease. The wild type strain
successfully colonized mouse bladders and kidneys and was highly virulent in intraperitoneal
infections. Conversely, the ΔkpsCS mutant was unable to colonize kidneys and was unable to
cause sepsis. These results demonstrate that some MAEC may be capable of causing human
ExPEC illness. Virulence of strain M12 in these infections is dependent on its capsule. However,
capsule may interfere with zinc homeostasis in the presence of bile salts while in the digestive
tract.
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3.2 Introduction
Escherichia coli strains are abundant members of the healthy intestinal flora of most
mammals and birds and may also be obligate or opportunistic pathogens. Strains that reside in
the digestive tract but cause disease in other tissues are termed extraintestinal pathogenic E.
coli (ExPEC) [240]. ExPEC are a major cause of urinary tract infections, neonatal meningitis,
pneumonia, and sepsis in humans. ExPEC also cause several diseases of agricultural importance,
including airway infections and septicemia in poultry [241]. Avian pathogenic strains present in
poultry products represent a significant risk for human infection [242].
ExPEC strains are not derived from a single lineage, but rather arise from frequent
recombination within diverse phylogenetic backgrounds [243]. Furthermore, there are no specific
virulence genes that are universally present in all ExPEC strains, although many genes that are
common in pathogenic strains have demonstrated roles in experimental infections. Among these
are genes that enable the bacteria to attach to and invade their hosts, resist the antimicrobial
effects of serum, scavenge for metal ions, or produce toxins [244].
E. coli are also the most frequent cause of bovine mastitis, which is responsible for
billions of dollars in losses annually to dairy producers [152]. The strains that cause mastitis
(Mastitis-Associated E. coli or MAEC) have traditionally been viewed as commensals that cause
disease solely through triggering inflammation in the mammary gland rather than as pathogens
[160]. As with ExPEC, there is not a reliable genetic marker that distinguishes MAEC from other
E. coli. Several recent comparative genomic studies of MAEC have highlighted the diversity of
these bacteria [164-167,245]. They have also noted that some MAEC carry genes associated with
virulence of ExPEC strains [156,245,246]. The function of these ExPEC virulence genes in
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MAEC has not been investigated. As these genes are also commonly found in commensal strains
that are not known to cause extraintestinal disease, their purpose may be to facilitate
gastrointestinal colonization and persistence [247,248]. These genes could also increase bacterial
survival and tissue damage during mammary gland (MG) infection by some strains. Finally, it is
also possible that some MAEC are fully capable of causing ExPEC-like disease, and
pathogenesis in extraintestinal sites depends on these virulence-associated genes.
We previously conducted a genome-wide TnSeq screen to identify fitness factors needed
by a MAEC strain (M12) to grow in milk and colonize mouse MGs [245]. We demonstrated a
role for an individual MAEC gene in mastitis for the first time. An M12 mutant lacking the fecA
gene was unable to grow in milk and was attenuated during MG infection. The fecA gene
encodes the ferric dicitrate receptor and is enriched among MAEC strains [205], but it is not
known to contribute to other ExPEC disease. ExPEC-associated virulence genes were also
identified as potentially contributing to MG colonization. These included genes for group III
capsule biosynthesis identical to those of the K96 serotype [249]. Elimination of the kpsCS
capsule genes from strain M12 resulted in a modest decrease in fitness in mouse MG
colonization. The TnSeq screen also suggested that the high affinity zinc uptake system encoded
by the znuABC genes may be important in colonizing MGs.
Between 5-6% of all E. coli proteins may require zinc binding for proper function [122],
making it an essential nutrient for bacterial growth. Since free zinc is limited in host tissues,
bacterial pathogens must scavenge for zinc to overcome defenses that are part of nutritional
immunity [250]. One important host zinc sequestration mechanism is the release of calprotectin
by neutrophils, which binds to zinc as well as other metals [251]. Infectious bacteria can
scavenge for zinc by releasing zincophores [252,253] or through high-affinity transport systems
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such as the Znu/Adc family [254-257]. The periplasmic zinc-binding protein ZnuA, integral
membrane subunit ZnuB, and ATP-binding subunit ZnuC actively import scarce zinc ions across
the inner membrane. Zinc scavenging via the Znu system enhances the virulence of several
bacterial pathogens including ExPEC [127,258-262], but its role in MG colonization is unknown.
High numbers of neutrophils infiltrate infected MGs during mastitis, so it is possible that
expression of the Znu proteins benefit MAEC strains in this environment.
In this study, we investigated the role of the ExPEC-virulence associated znuABC genes
in the MAEC M12 strain. We show that a M12 ΔznuABC mutant has decreased survival in
mouse MGs. We also observed that the M12 ΔznuABC mutant has a pronounced growth delay
when exposed to bile salts. Further examination of this growth defect uncovered a link between
the presence of bile salts, zinc uptake and capsule production, where capsule appears to limit
bacterial growth when bile salts are present. Conversely, we demonstrate that capsule synthesis
is required for strain M12 to cause ExPEC-like disease including urinary tract infection and
sepsis.
3.3 Results
3.3.1 Role of znuABC in colonization of mouse mammary glands
Our previous TnSeq analysis suggested that the high-affinity zinc transport system
(znuABC) is essential for MAEC strain M12 to colonize mouse MGs [245]. The znuABC locus
contains two divergently transcribed units; znuCB are transcribed together while znuA is
transcribed divergently (Fig. 3.1A). Reexamination of our TnSeq data suggested that Tn
insertions in znuA or znuC but not in znuB are detrimental to M12 colonization of MGs [263]. In
order to ascertain the importance of this system, we chose to delete the entire znuABC gene
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cluster from strain M12. To confirm that the ΔznuABC mutant strain was sensitive to zinc
limiting conditions, the mutant and the wild type M12 strains were cultured in the presence of
the divalent cation chelator EDTA. The ΔznuABC mutant grew significantly more slowly
compared to the wild type strain (Fig. 3.1B). Complementation via a low-copy plasmid restored
the ability of the mutant to grow in EDTA-containing media (Supplemental Figure S.4B).
Growth of the ΔznuABC mutant strain also resembled that of the wild type when excess zinc was
added to the media with EDTA. Manganese and copper did not restore growth of the ΔznuABC
mutant strain (Fig. 3.1B), even up to levels that slowed growth of the wild type strain
(Supplemental Figure S.4C&D). These results demonstrate that the M12 ΔznuABC mutant is
specifically deficient in its ability to acquire zinc. We then tested the fitness of the mutant strain
in conditions relevant to mastitis, including growth in milk and during infection of lactating
mouse MGs. Competition assays demonstrated that loss of znuABC did not significantly affect
fitness during growth in milk, but it resulted in an approximately 10-fold competitive
disadvantage compared to wild type bacteria in mouse MGs (Fig. 3.1C).
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Figure 3.1 Role of the znuABC zinc transporter in the mastitis-associated E. coli M12 strain.
(A) The znu locus of strain M12 and the 2560 bp region that was deleted to create the ΔznuABC
mutant strain. The normalized TnSeq fitness scores predicted for each gene as calculated by
Rendon et al. [263] are indicated. (B) Growth of M12 wild type, the ΔznuABC mutant, and the
complemented strain ΔznuABC (pMO3) in LB broth containing 0.5 mM EDTA. The mutant
displayed a significant delay in growth that was fully restored with the addition of 100 μM zinc
or by complementation with the plasmid pMO3. Addition of excess zinc did not affect the
growth of the wild type strain. (C) Competitive fitness of the ΔznuABC mutant compared with
the M12 wild type strain during growth in milk or in mouse mammary glands. Equal ratios of
both strains were inoculated in unpasteurized bovine milk or injected through the teat canal of
lactating mice. Bacterial numbers were determined after 8 hours and 24 hours respectively. The
mutant strain was significantly less fit (*p=0.03125 by Mann-Whitney test) than the wild-type
strain in mammary glands but not in milk.
3.3.2 Effect of znuABC on growth in the presence of bile salts
In these experiments, the competing strains were selected on MacConkey agar plates
after growth in milk or mammary glands. We observed that when the ΔznuABC mutant was
grown on MacConkey agar plates, colonies took 3-4 days to appear, but when grown on LB agar
it grew at the same rate as the wild type strain. Bile salts and crystal violet are the primary
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constituents of MacConkey agar that select for Gram-negative enteric bacteria. In order to
determine what was responsible for the delayed growth of the mutant strain, we tested growth in
LB media containing bile salts or crystal violet. While crystal violet had no effect, the ΔznuABC
mutant exhibited a delayed growth phenotype in media containing as little as 0.5% bile salts
(Fig. 3.2A). Total growth yield was the same for both wild type and mutant bacteria. The growth
rate during exponential phase appeared to be the same, but the mutant did not enter exponential
growth phase until 12-14 hours after inoculation.
Bile salts have detergent qualities that damage bacterial membranes. To determine if loss
of znuABC causes a generalized membrane defect, we investigated whether the mutant strain had
attenuated or delayed growth in SDS detergent or polymyxin B antibiotic, both of which can
disrupt membrane integrity. The ΔznuABC did not have a growth defect in either SDS or
polymyxin (Fig. 3.2B& C). As the ΔznuABC mutant does not have a generalized membrane
defect, our results suggest a novel role for bile resistance that is dependent on zinc utilization. In
support of this interpretation, addition of supplemental zinc (1 mM) to the media with bile salts
decreased the time it took for the ΔznuABC mutant to enter exponential phase (Fig. 3.2A).
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Figure 3.2 Loss of znuABC delays growth of strain M12 specifically in the presence of bile salts.
(A) Growth of M12 or ΔznuABC mutant in LB media containing 2% bile salts. The mutant strain
entered exponential growth phase several hours later than the wild type but had similar
absorbance at 600 nm and during the saturation phase. Addition of 100 μM zinc to the media
decreased the time it took for the ΔznuABC mutant to enter exponential phase. Identical growth
curves of the wild type M12 and ΔznuABC mutant in 5% SDS (B) or 2 μg/ml of polymyxin E
(C) showing that the mutation does not confer a generalized membrane defect.
3.3.3 Suppressor mutant screen suggests a link between K96 capsule and growth in bile
salts
The ΔznuABC mutant grew to the same density as the wild type strain after 24 hours. We
wanted to determine if these bacteria that had grown in the bile salt media would exhibit the
same growth delay when subcultured in the same media. Transfer of these bacteria directly into
LB+bile salts showed that they entered into exponential phase at the same time as the wild type
strain. This suggested that the mutant strain adapted to the bile salts, either through changes in
gene expression or through compensatory mutations or both. We then plated the bile-salt-adapted
mutant strain on LB agar without bile salts to obtain single colonies. These colonies were then
cultured in broth with bile salts (Fig. 3.3A) to see if the lag in growth reappeared. The “adapted”
mutants grew at the same rate as the wild type strain, suggesting that suppressor mutants readily
arose among the ΔznuABC mutant population in the presence of bile salts.

58

To identify the genetic basis for these suppressor mutations, we serially passaged ten
separate cultures derived from the ΔznuABC parent strain in the presence of 2% bile salts for
approximately 200 generations. From these cultures, we isolated individual colonies on LB agar
plates and then tested their growth profiles in bile salts compared to the wild type or ΔznuABC
strains (Fig. 3.3B). All of the colonies we isolated grew more rapidly than the wild type strain in
LB with bile salts. The genomes of the ten suppressor mutants as well as the ΔznuABC mutant
parent strain were sequenced and non-synonymous SNPs within predicted coding regions were
identified (Table 3.1). Three of the mutants had nucleotide substitutions in the rpoA gene
encoding the alpha-subunit of RNA polymerase. All three mutations are predicted to change
asparagine 294 to a histidine or lysine. Four mutants contained SNPs in the dedD or in ftsK genes
that are predicted to result in non-functional alleles, either eliminating start codons or introducing
premature stop codons. DedD and FtsK are both proteins involved in cell division. Finally, three
suppressor mutants contained SNPs in glycosyltransferase genes found in a cluster associated
with biosynthesis and export of a K96 group III capsule.
Table 3.1 SNPs identified in ΔznuABC *suppressor mutants with enhanced growth in bile salts.
Strain

Gene

Mutation

Function

SM1

ftsK

SM2

CO715_12230

E45Stop

Capsule synthesis, Glycosyl transferase family
2

SM2

folC

G421S

Dihydrofolate synthase/folylpolyglutamate
synthase

SM3

dedD

Q35Stop

Cell division protein

212_213insTGGCAGA Chromosome segregation in cell division
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SM4

rpoA

N294H

RNA polymerase alpha subunit

SM5

rpoA

N294H

RNA polymerase alpha subunit

SM7

rpoA

N294H

RNA polymerase alpha subunit

SM8

dedD

V1L

Cell division protein

SM8

CO715_12235

V149G

Capsule synthesis, Glycosyltransferase family
1

SM10

CO715_12210

D15N

Capsule synthesis, Glycosyltransferase family
1

SM10

dedD

V1A

Cell division protein

*In suppressor mutants 2, 8, and 10 two SNPs were identified and no SNPs were detected in the
CDS for suppressor mutant 6.
These results suggested a link between capsule production and growth in bile salts.
Therefore, we sought to determine whether these glycosyltransferase gene mutations altered
capsule production. We also wanted to determine whether the other suppressor mutants produce
capsule normally. We compared capsule synthesis of M12 wild type, the ΔkpsCS mutant, and
each of the suppressor mutant strains (Fig. 3.3C) using SDS-PAGE and alcian blue staining. The
suppressor mutants with changes in capsule glycosyltransferase genes did not produce detectable
capsule. Surprisingly, several of the other suppressor mutants also failed to produce capsule,
even though their mutations did not map to predicted capsule loci. This suggested that capsule
production is detrimental to growth of strain M12 in bile salts. To test this directly, growth of the
wild type M12 strain and the ΔkpsCS mutant were compared in LB or LB+2% bile salts (Fig. 3.3
D&E). Although growth in LB was identical, the ΔkpsCS mutant strain entered exponential
phase more quickly than the wild type strain when bile salts were present.
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Figure 3.3 Suppressor mutations in the ΔznuABC background that restore growth in bile salts
also eliminate capsule synthesis.
(A) Saturated cultures of the wild type strain and the ΔznuABC mutant grown in LB + bile salts
and subcultured in the same media exhibited similar growth rates, suggesting the possibility of
suppressor mutations arising in the population. (B) Ten independently derived suppressor
mutants had increased growth in LB media containing 2% bile salts when compared to the wild
type strain. Whole-genome sequencing indicated that suppressor mutants 2, 8, and 10 contained
SNPs that mapped to predicted capsule synthesis genes. (C) Gel electrophoresis and alcian blue
staining shows that 8 of 10 suppressor mutants produce less capsule than the wild type strain. (D,
E) A ΔkpsSC mutant unable to produce capsule reaches exponential phase faster than the wild
type strain when grown in LB with bile salts but growth in LB is indistinguishable from the wild
type strain.
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Our results suggested that capsule may delay exponential growth of the bacteria when
bile salts are present. This raised the possibility that capsule production may be influenced by the
presence of bile salts. To test this, we grew the wild type strain M12 in LB or in LB+2% bile
salts to examine how these conditions affected capsule synthesis. We also tested ExPEC strain
CP9, which belongs to serotype K54. The chemical structure of K54 and K96 capsules are nearly
identical [81]. When analyzed by alcian blue staining of gels, capsule synthesis appeared to be
strongly repressed in both M12 and CP9 strains when grown in bile salts (Fig. 3.4A). We also
used flow cytometry to measure capsule attached to intact bacteria. K54 antiserum bound
strongly to both M12 and CP9 bacteria when grown in LB, but far more capsule-negative
bacteria were detected when they were grown in LB + 2% bile salts (Fig. 3.4B).

Figure 3.4 Growth in bile salts reduces capsule expression by strain M12 and ExPEC strain CP9.
(A) Gel electrophoresis and alcian blue staining of capsule produced by M12 and CP9 grown in
LB media or LB media containing 2% bile salts. (B) Capsule measurement by flow cytometry. In
both M12 and CP9, the proportion of bacteria that were positively stained with K54 α-capsule
serum detectable was less when grown in bile salts than in LB alone.
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3.3.4 Mastitis strain M12 causes urinary tract infection and sepsis in mice
MAEC strains circulate in the digestive tracts of dairy cattle and colonize mammary
glands via environmental contamination. Our results suggest that capsule production may slow
MAEC growth in the digestive tract where bile salts are present. Our previous work had also
shown that the capsule of strain M12 contributes modestly to MG infection but is not required,
which prompted us to further investigate the role of this capsule. Several MAEC strains possess
similar genes for type II or type III capsules. They are required for some ExPEC strains to
colonize the urinary tract and/or bloodstream. To investigate whether strain M12 could also
infect these tissue sites, we used established rodent models of these human infections. First, we
infected mice via intraperitoneal injection to mimic sepsis caused by ExPEC. We compared
strain M12 with strain CP9 that is known to cause sepsis in this model. The wild type M12 strain
was highly virulent in these mice, which exhibited signs of terminal illness and were euthanized
after 24 h. High numbers of bacteria, similar to strain CP9, were recovered from infected spleens
when the mice were sacrificed (Fig. 3.5A). We also tested whether the K96 capsule was
important for strain M12 to cause sepsis. In contrast to the wild-type strain, mice infected with
the M12 capsule mutant strain (ΔkpsCS) appeared healthy and far fewer bacteria were recovered
from the spleens. We then tested whether strain M12 could infect the urinary tracts of mice. As
with the intraperitoneal infections, strain M12 was very successful in the urinary tract, colonizing
the bladders and kidneys of infected mice to high levels (Fig. 3.5B). The M12 ΔkpsCS mutant
also efficiently colonized the bladders of the mice. However, the mutant strain was very
attenuated in the kidneys and very few bacteria were recovered (Fig. 3.5B).
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Figure 3.5 Virulence of mastitis-associated strain M12 in ExPEC infections depends on capsule
production.
|(A) M12 wild type, M12 ΔkpsCS mutant and ExPEC CP9 strains (~5x105 CFU) were injected
into the intraperitoneal cavity of C57BL/6 mice and bacterial loads in the spleens were
determined at 24 hours. Both M12 wild type and CP9 strains were recovered at high levels in the
spleen while the ΔkpsCS mutant was severely attenuated (p=0.0303 by Mann-Whitney test). (B)
Adult female Swiss-Webster mice were inoculated via transurethral catheterization and
sacrificed 72 hours later. Both M12 wild type and ΔkpsCS colonized the bladders of the mice to
similar levels but in the kidney the mutant strain was not detected (p=0.0003 by Mann-Whitney
test).
3.4 Discussion
ExPEC are not defined by their lineage or carriage of any particular gene, but rather by
their capacity to colonize specific tissue sites. However, some factors do tend to be more
common in specific pathotypes including P fimbriae in uropathogenic strains [264], aerobactin
siderophore and increased serum survival (iss) in avian pathogenic strains [265], and sialic acid
capsule in neonatal meningitis E. coli strains [266]. MAEC strains have not previously been
grouped under the ExPEC umbrella, even though some carry these virulence genes. Recent
efforts to better understand the genomes of MAEC strains have uncovered certain features that
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tend to be associated with this group of bacteria [165-167,267,268]. For example, MAEC are
more likely than other strains to express the ferric dicitrate receptor, and this improves bacterial
growth in milk and lactating mammary glands [245]. It is now clear that all E. coli are not
equally capable of causing mastitis and that the disease outcome depends greatly on the nature of
the infecting strain rather than simply on host factors alone. For instance, strains that cause
persistent mastitis tend to be more motile and more resistant to complement than those that cause
transient disease [268]. Our results indicate that some classic ExPEC factors such as capsule and
metal scavenging systems may also enhance growth of some strains in MGs. More frequent
systemic spread or severe tissue damage would logically follow from prolific growth in the
udder, and these ExPEC virulence factors may also contribute to bacterial survival beyond the
MG.
Our interest in the role of the znuABC system stemmed from our previous TnSeq data
that indicated it is required for M12 fitness in MGs and during Galleria mellonella infections
[245], suggesting that the bacteria experience zinc starvation in these environments. In MGs, the
S100 family of EF-hand proteins are thought to limit availability of transition metals (reviewed
in reference [269]) Psoriasin (S100A7), a zinc-binding protein produced by keratinocytes, is
found abundantly in mammary epithelia and is capable of inhibiting E. coli growth in vitro or in
skin lesions [144,270]. Neutrophils also infiltrate infected MGs quickly after infection and are
critical to the containment of the bacteria and limiting tissue damage [216]. They release
calprotectin (S100A8 and S100A9) to significantly limit extracellular zinc in addition to other
metals [271]. Resident macrophages also engulf MAEC, where the bacteria may also face toxic
levels of excess zinc [272]. Thus, systems to maintain zinc homeostasis may be key fitness
determinants for these bacteria.
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We were surprised to find that bile salts delayed growth of the M12 ΔznuABC mutant.
Mutants lacking these genes have been made in other E. coli strain backgrounds but no similar
growth defects on MacConkey agar were reported. Whether znuABC mutations in other strain
backgrounds confer growth defects in bile salts deserves further investigation. Bile
concentrations reach levels between 0.2–2.0% in the small intestine [273]. Due to the detergent
properties of bile, it is capable of disrupting bacterial membranes and crossing into the cell,
which can induce DNA damage and oxidative stress [274,275]. Bacteria employ multiple tactics
to combat the disruptive effects of bile, including outer membrane modifications, efflux pumps,
and DNA repair systems [273]. It is likely that variation of cell envelope features such as capsule
or lipopolysaccharide greatly influence the sensitivity of different strains to bile salt stress. This
znuABC mutant to grow in the
presence of bile salts. The K96 capsule made by M12 consists of glucuronic acid and rhamnose
and has a strong negative charge [81]. It is conceivable that this capsule interferes with zinc
cation movement into the cells when the high affinity Znu system is not present and zinc is not
readily available. Our results indicate that bile salts may confer this type of stress, reducing the
amount of zinc available for bacterial growth.
To our knowledge, there are no reports of bile salts specifically conferring zinc stress in
other bacteria. However, the secondary bile acid deoxycholic acid can form organometallic
complexes with zinc and other heavy metals which may make them unavailable for import,
potentially affecting gene expression in many enteric bacteria [276-279]. E. coli O157:H7 is
reported to increase expression of iron acquisition genes when exposed to bile, but repress key
virulence genes including shiga toxin and the locus of enterocyte effacement [280]. We found
that both the MAEC strain M12 and the human sepsis strain CP9 repress production of capsule in
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the presence of bile salts. These bacteria may benefit from repressing virulence factors while
transiting through the small intestine until the appropriate target sites are reached; the colon in
the case of EHEC, and extraintestinal tissues for M12 and CP9. The relevant sensing
mechanisms and the level at which the regulation is achieved remain to be identified.
Furthermore, it is not yet clear whether the influence of bile salts on capsule production occurs
through its effect on zinc availability or via sensing bile salts directly. Zinc regulation of capsule
production in bacteria is not without precedent; in Streptococcus pyogenes, high levels of zinc
such as are found within neutrophil phagosomes inhibit the phosphoglucomutase enzyme needed
to initiate capsule synthesis [281].
ExPEC capsules impact pathogenesis in non-uniform ways. More than 100 distinct
capsule types have been described, which are categorized into four groups based on gene
organization and mode of assembly and export [193]. Strain CP9 produces a K54 capsule
belonging to group 3 that has a strong effect on virulence. CP9 mutants lacking this capsule were
highly attenuated in mouse bloodstream infections and in a rat model of abscess formation [219].
However, loss of the K54 capsule did not have a measurable effect in the ability of strain CP9 to
colonize mouse bladders or kidneys during urinary tract infections [282]. Most uropathogenic
ExPEC strains produce capsule belonging to group 2. For instance, strain CFT073 produces a K2
capsule that was shown to have a modest effect in promoting colonization in mouse bladders
[221,222] and a more important role in kidneys [221]. In UPEC strain 536, production of the
K15 capsule was proven to contribute dramatically to urovirulence in neonatal mice [220]. In
these studies, mortality of the mice was measured and not bacterial loads in the bladder or
kidneys, so it is unclear at which stage colonization was affected.
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We have shown that an MAEC strain M12 colonizes both bladders and kidneys during
experimental urinary tract infections and causes lethal sepsis in mice (Fig. 3.5). In both cases, the
production of K96 capsule was a critical virulence determinant for colonization of kidneys and
spleens. Previously our group showed that this mutant is also highly attenuated in G. mellonella
[245]. It is interesting that the capsules of strains M12 and CP9 are identical but in CP9 the
capsule is dispensable for kidney infection via the urinary tract [282], whereas our results show it
is required in strain M12. Absence of the K96 capsule of M12 did not detectably alter bladder
colonization (Fig. 3.5) and has a moderate effect in MGs. The exact function of the M12 capsule
in these specific tissues is not yet understood. ExPEC capsules may have a role in avoiding
killing by phagocytes [69]. The capsules of some ExPEC strains are required for serum
resistance, while in other strains the loss of capsule has no effect [283-286]. ExPEC capsule can
also help in the establishment of intracellular bacterial communities within epithelial cells of the
urinary tract [287]. The fact that some MAEC strains carry capsule and other ExPEC virulence
genes has been noted previously, but ours is the first study to show that a MAEC strain is
capable of causing urinary tract infection and sepsis in established models of human disease.
Non-pathogens may carry ExPEC virulence factors because they promote intestinal colonization
rather than infection, depending on the strain background. However, as we have shown here,
some MAEC strains may not be purely commensals or accidental pathogens, but rather versatile
organisms fully capable of causing human illness in addition to bovine mastitis.
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3.5 Experimental Procedures
3.5.1 Bacterial strains and growth conditions
E. coli strain CP9 is a human bloodstream isolate that has been previously described in
detail [288]. E. coli strain M12 and the M12 ΔkpsCS mutant were previously characterized [245].
E. coli strains were routinely grown in Luria-Bertani (LB) medium at 37°C. To select for mutant
strains or carriage of plasmids, growth medium was supplemented with chloramphenicol (10
µg/ml), or ampicillin (100 µg/ml) as appropriate. For milk cultures, whole unpasteurized cow’s
milk was obtained from a local supplier and used immediately or stored at -80°C until use.
Growth curves were generated using a Bioscreen C system (Labsystems Oy, Helsinki, Finland).
Bacterial cultures were standardized to 5x104 CFU/mL and absorbance at 600 nm was measured
every 15 minutes while continuously shaken at 37°C. LB growth medium was supplemented
with 2% bile salts, 2 μg/ml polymyxin B, 5% SDS, 100 μM EDTA, 100 μM zinc chloride,
copper sulfate or manganese sulfate as appropriate. All chemicals were purchased from SigmaAldrich. For competition assays during growth in milk, equal ratios of M12 and ΔznuABC
mutant was inoculated into whole unpasteurized cow’s milk and incubated at 37°C for 8 h. CFU
ratios of the input and output for M12 and ΔznuABC, determined by plate counts, were used to
calculate a competition index.
3.5.2 Deletion and complementation of znuABC
Mutation of znuABC was performed via lambda red recombination in strain M12 carrying
the plasmid pKD46 [235]. A PCR product was created using pRE112 [289] as a template to
amplify the chloramphenicol acetyltransferase gene, with 50 bp overhangs homologous to the 5’
end of znuB or the 3’ end of znuA. Bacteria expressing the recombinase enzymes were
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electroporated with 500 ng of purified DNA, and potential mutants were selected by plating on
LB agar containing chloramphenicol. Potential mutants were then screened by PCR using
primers flanking the recombination site and also with primers internal to the znuB and znuA
znuABC mutation and absence of other SNPs was also confirmed by whole
genome sequencing (Microbial Genome Sequencing Center, University of Pittsburgh).
Complementation of znuABC was created by generating PCR products of the znuABC gene
cluster and the pACYC184 backbone. There products were combined in an overlapping
extension PCR mixture and transformed into E. coli DH5α to create plasmid pACYC- znuABC
(pMO3). pMO3 was later isolated and transformed into M12

znuAB.

3.5.3 Suppressor mutant sequencing, assembly, and annotation
Total DNA was isolated from suppressor mutants using a ZR Fungal/Bacterial DNA
MiniPrep kit (Zymoresearch). DNA sequencing libraries were prepared using the Illumina
Nextera DNA library Prep kit with modifications [290]. DNA libraries were sequenced by
Genewiz, Inc. (South Plainfield, NJ) and Illumina paired-end reads of 150 bp were generated on
MiSeq version 2 sequencer. Contigs, annotations and SNP analyses were compiled using
EnteroBase [291,292].
3.5.4 Capsule isolation and staining
Capsule production was visualized as previously described [293]. Briefly, bacteria were
pelleted from 1 ml of saturated overnight cultures grown in LB broth. The bacterial cells were
then resuspended in 50 µl of PBS and heated to 55°C for 30 min. The capsule material analyzed
by electrophoresis on 10% SDS-polyacrylamide gels and staining with 0.125% alcian blue dye in
40% ethanol–5% acetic acid.
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3.5.5 Flow cytometry
Bacteria were grown in LB broth or LB broth supplemented with 2% bile salts for 24 h.
Saturated overnight cultures were diluted 1:100 in 0.1% BSA-PBS with undiluted anti-K54
rabbit antisera (SSI Diagnostica) and incubated for 30 minutes on ice. Samples were washed
with 0.1% BSA-PBS and stained with Goat anti-Rabbit IgG (H+L) secondary antibody, Alexa
Fluor Plus 594 (Invitrogen) in the dark for 30 minutes. The fluorescence of individual bacterial
cells was measured using a BD Accuri C6 flow cytometer and histograms were generated with
FlowJo™ Software. Negative control samples contained bacteria with the secondary Ab only or
without primary and secondary Ab.
3.5.6 Ethics statement
Mouse experiments were performed in accordance with the recommendations found in
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (83).
The protocol was reviewed and approved by the Institutional Animal Care and Use Committees
of Brigham Young University and the University of Utah.
3.5.7 Mouse infections
Mouse mammary gland infections: Lactating C57BL/6 mice between 9 and 12 weeks of
age and 10 to 11 days postpartum were infected as previously described [245]. Briefly, a 50 µl
volume of bacteria containing 250 CFU of both wild type M12 and the ΔznuABC mutant strain
in PBS was injected directly through the teat canal into the ductal network of the 4th left and 4th
right mammary glands of 3 mice using a 33-gauge needle with a beveled end. Pups were
removed for 1 to 2 h after injections and then were returned. Mice were euthanized after 24 h and
mammary gland tissue was harvested. Bacterial loads were determined by homogenizing tissue
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in 1 ml of PBS, performing serial dilutions and plating on selective agar. CFU ratios of the input
and output for M12 and ΔznuABC, determined by plate counts, were used to calculate a
competition index.
Mouse intraperitoneal infections: Equal numbers of male and female C57BL/6 mice
between 9 and 12 weeks of age were used for all infections. Bacteria were grown overnight in
LB, subcultured to an absorbance of 1.0 at 600 nn, and serially diluted in PBS. A 200 µl volume
of bacteria containing 5x105 CFU in PBS was injected directly into the intraperitoneal cavity
using a 27 ½ -gauge needle. The concentration of each inoculum was determined by serial
dilution and colony counting after 24 h growth on LB agar plates. Mice were monitored for 24 h
and spleens were harvested. Bacterial loads were determined by homogenizing entire spleens in
1 ml of PBS, performing serial dilutions, and colony counts.
Mouse urinary tract infections: Adult (~8 weeks) female Swiss-Webster mice (Charles
River) were used in all experiments Bacteria were grown statically from frozen stocks in 20 mL
M9 minimum medium for 24 h at 37°C. Bacteria were pelleted at 8,000 RCF for 8 minutes and
resuspended in 3 mL sterile PBS. Mice were inoculated with a 50µl volume (5x108 CFU) via
transurethral catheterization and sacrificed 3 days later. Kidneys and bladders were weighed,
homogenized, and CFU determined by serial dilution and plating.
3.5.8 Statistical analyses
All mouse infection data were analyzed using GraphPad Prism 5.0. The statistical tests
performed as well as the significance values are indicated in the individual figure legends.
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Chapter 4 Identifying Escherichia coli genes associated with clinical mastitis severity and fitness
in experimental models of disease
4.1 Abstract
Mastitis caused by Escherichia coli is a considerable obstacle in dairy production, and the
strains associated with this disease negatively impact health of animals and possibly humans.
While host (cow) factors are known to contribute to mastitis severity, little is known about
bacterial factors that impact the outcome of this infection. In this study, we sequenced the
genomes of 83 mastitis-associated E. coli (MAEC) strains isolated from cattle diagnosed with
mild or severe disease. DNA barcodes were also added to these strains in order to track their
competitive fitness during experimental infections and in vitro growth. We found that MAEC
strains are highly genetically diverse, belonging to several multi-locus sequence types, and that
they may carry virulence factors associated with other extraintestinal pathogenic strains. Using a
pan-genome wide association approach, we identified accessory genes that are associated with
mild or severe disease as well as those strains that with high or low fitness during mammary
gland infections or growth in milk. These include genes encoding adhesive factors (Yad fimbriae
and chitinase) as well as genes that promote immune avoidance or biofilm production
(extracellular polysaccharide and capsule/O-antigen synthesis). These results provide a much
richer understanding of MAEC and suggest bacterial processes that may underlie the clinical
diversity associated with mastitis.
4.2 Introduction
Bovine mastitis is a significant economic burden to the dairy industry, which incurs
billions of dollars of losses each year [294]. Mastitis is the inflammation of the mammary gland
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(MG) and is typically caused by bacterial infections, E. coli being the most common in the dairy
industry. Mastitis-associated E. coli (MAEC), abundant in the dairy environment, gain access to
the mammary gland (MG) via the teat canal. As they colonize, the bacteria need to overcome
both nutritional and innate immune factors in order to cause disease. Once established within the
MG, these pathogens can lead to a range of clinical presentations. Mild mastitis usually involves
increased somatic cell counts in the milk, mild inflammation caused by the influx of neutrophils
and proinflammatory cytokines, and the infection is cleared without complication or antibiotic
intervention [295,296]. Conversely, severe mastitis can damage the gland due to high levels of
inflammation and bacterial loads. Infected cows may be culled because of permanent damage to
the gland or if the infection becomes systemic, leading to sepsis [297,298].
Mastitis severity depends on many cow factors that contribute to disease outcome. For
instance, the successful clearance of bacteria from the MG is contingent on the regulation and
strength of the innate immune system, which is dependent on the stage of lactation when the MG
becomes infected. Cows at the time of parturition and earlier stages of lactation are more prone
to severe mastitis outcomes, which is attributed to the immunological dysfunction of neutrophils
and lymphocytes at this time [20-24,299]. In addition to host immune factors, researchers have
noted that individual MAEC strains tend to cause either mild or severe disease, which can have
either a persistent or transient character. Transient strains do not establish long-term residence in
the mammary gland. Persistent strains are distinguished by their ability to gain access to the
mammary gland during the non-lactating period and persist within the mammary gland. When
lactation begins, these strains cause symptoms of clinical mastitis, which can lead to chronic
infections [300,301]. Both transient and persistent disease may be mild or severe.
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The relationship between MAEC strains and other E. coli types is not clear. Phenotypes
that seem to be associated with MAEC strains include the utilization of ferric citrate as an iron
source, resistance to the complement system, and high motility levels [17,172,302,303]. Genes
that are associated with MAEC have been examined in numerous PCR-based surveys and a few
genomic studies [27,303-306]. These have shown that the majority of MAEC strains fall within
the phylogroups A and B1, which are the same phylogroups of most commensal strains.
Nevertheless, commensal strains are unable to cause chronic or acute mastitis [27], suggesting
that there are fundamental differences between commensal and MAEC strains. Multilocus
sequencing typing (MLST) studies suggest that MAEC are not limited to specific lineages but
frequently belong to STs 10, 58, 95, and 1125 [15,26,38,307-309].
We previously conducted a functional genetic screen using transposon insertion
sequencing (Tn-Seq) to identify the fitness factors of a single MAEC strain. We showed that this
strain's ferric dicitrate transport system encoded by the fecABCDE genes is needed to colonize
lactating mouse mammary glands. The fec operon is strongly associated with MAEC strains
compared to other E. coli populations. This study also implicated the high-affinity zinc transport
system, and several genes involved in other metabolic pathways in fitness in MGs. However, this
study was limited to one strain [17]. Different genes may be required in other strain
backgrounds. Carriage of specific genes might also be correlated with their propensity to cause
mild or severe mastitis.
We hypothesize that in addition to cow factors, there are also bacterial factors that
influence mastitis severity. For instance, swarming motility was recently shown to be higher in
MAEC strains isolated from severe mastitis cases than those strains isolated from mild and
moderate cases [302]. The ability to proliferate rapidly in milk may also contribute to mastitis
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severity. For example, the strain M12 fecA mutant grew poorly in milk and did not replicate to
high numbers in the lactating mammary gland, resulting in less severe disease. Comparative
genomics may be a useful approach to identifying bacterial genes that affect severity. MAEC
strains are known to carry virulence factors often found in other ExPEC pathotypes such as
toxins, siderophores, and adhesins, but the carriage of these specific virulence factors does not
seem to correlate with mastitis severity [302,310,311]. A more sensitive approach is needed to
uncover a genetic link between bacterial factors and mastitis severity than limited sequence
comparisons and PCR approaches. However, relatively few full genome sequences are available
for MAEC strains. In this study, we sequenced the genomes of 83 MAEC strains isolated from
mild or severe mastitis cases and implemented a genome-wide association approach to identify
genes associated with mastitis severity in dairy cattle. We also tested these strains during
competitive in vitro growth or during mouse and cow mammary gland infections. Our analysis
suggests that several genes involved in the biosynthesis of Yad fimbriae are positively associated
with severe mastitis. Yad fimbriae have been previously identified as important for the adhesion
of uropathogenic strains in the urinary tract as well as environmental persistence [52,53,55].
Conversely, we find that several tyrosine recombinases and biofilm PGA synthesis genes are
negatively associated with severe mastitis. Biofilm production may promote chronic disease and
limited inflammatory responses. Genes linked to increased bacterial fitness include a type II
secretion system and a secreted chitinase in a mouse MG, and two rhamnose biosynthesis genes
in a cow MG. A secreted chitinase was determined to be necessary for adhesin to the intestinal
epithelium for adherent and invasive E. coli, while the rhamnose moiety can be found in the Oantigen and capsules.
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4.3 Results and discussion
4.3.1 Growth in milk is not associated with mastitis severity.
Our study population included 83 MAEC strains isolated from mastitic cows from several
regions across Canada. At the time of collection, a veterinarian evaluated the clinical signs
presented in each affected animal and assigned a mastitis score (1-3, mild-severe). Strains
isolated from cows in the middle to late stages of their lactation cycle were selected in an attempt
to focus on bacterial factors that contribute to mastitis and minimize cow factors that affect
mastitis severity. From this group, 41 strains associated with mild (mastitis score=1) and 42
strains from severe (mastitis score = 3) disease were chosen for analysis.
The ability to efficiently utilize the nutritional components present in milk and thus grow
rapidly in milk may be a determining factor for some strains ability to colonize the mammary
gland successfully. To determine if there is a link between growth in milk and mastitis severity,
we compared the growth of 78 of our MAEC strains in whole unpasteurized cow’s milk (Fig.
4.1). Bacterial replication of 34 mild and 39 severe strains was measured after 4 or 8 hours of
growth. MAEC strains varied widely in their growth yields, with some strains replicating 100fold within 4 hours and up to 100,000-fold by 8 hours, whereas other strains did not appear to
increase at all in that time period. However, we did not find a significant difference in growth
between these two groups of strains that cause mild and severe mastitis at either time point (Fig.
4.1). This is consistent with other results showing that in vitro growth in whole milk is not
associated with in vivo bacterial growth or mastitis severity [312,313].
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Figure 4.1 In vitro growth in milk of MAEC strains isolated from mild or severe mastitis
The growth of 78 MAEC strains was measured in whole unpasteurized milk at 4h and 8h.
Approximately 5000 CFU of bacteria were inoculated and the fold change relative to the
inoculum was determined by colony counts. 34 mild and 39 severe strains growth in whole
unpasteurized milk were compared at 4h and 8h. There were no statistically significant
differences between these two groups at either 4h or 8h (P value by Student's t test)

4.3.2 Relationship of mastitis severity with multi locus sequencing type and virulence
gene carriage
Complete genome sequences for 83 MAEC isolates, representing 41 mild and 42 severe
strains, were assembled and annotated from our study population. This was accomplished
through Illumina sequencing, generating 150 bp paired end reads. The reads were assembled and
annotated using the Enterobase pipeline, which is a repository of genomes from enteric bacteria
including E. coli. From these annotated sequences, we identified a total of 15395 unique genes
representing the pan-genome using the Roary pipeline [314]. The core genome consisted of 3177
genes, which were found in 98% of the strains.
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In silico phylogroup analysis was performed using ClermonTyping, which showed that
the majority of strains belong to phylogroups A and B1 [315]. Multilocus sequence typing based
on seven house-keeping genes was also used to more precisely assess the phylogenetic
backgrounds of the MAEC strains [316]. A total of 13 different STs were identified, with six STs
being represented by only one strain each. This suggested that these MAEC strains belong to a
wide range of sequence types. A metadata analysis of 217 studies, which included 15,538
ExPEC isolates, found that 20 MLST accounted for 85% of E.coli isolates; these include ST131,
ST69, ST10, and ST23 [317]. ST10, ST23, and ST155 were the most abundant, representing
75% of our study's total strains (Table 4.1). However, MLST groupings were not correlated with
mild or severe mastitis, as determined by a Mann-Whitney test. In previous published genomic
studies of MAEC strains, most were classified as ST10, ST1125, ST58, ST23, or ST88 and
phylogroups A or B1, which is consistent with our findings [26,305,307].
Table 4.1 ClermonType and MLST* for MAEC Strains
Strain
M100
M102
M103
M104
M105
M106
M107
M108
M109
M110
M111
M114
M115
M116
M117
M22

Clermont
type
B1
B1
A
A
cladeI
A
A
B1
A
A
A
B1
cladeI
C
A
A

MLST
ST155
ST10

ST10
ST10
ST10
ST469
ST10
ST155
ST23
ST398
ST165
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M23
M24
M25
M26
M28
M30
M31
M33
M34
M35
M36
M37
M38
M39
M40
M42
M43
M44
M45
M46
M47
M48
M49
M50
M51
M52
M54
M55
M56
M57
M58
M59
M60
M61
M64
M67
M68
M69
M70
M71
M72

A
A
B1
B1
B1
A
D
B1
A
B1
A

ST10
ST10
ST448
ST155
ST155
ST467
ST69

B1
B1
B2
A
B1
A
C
A
A
B1
B1
A
C
A
A
A
A
A
B1
A
B1
B1
A
B1
A
A
A
B1
A

ST10
ST101
ST12
ST10
ST23
ST10
ST23

ST10

ST155
ST469
ST23
ST10
ST10

ST10
ST10
ST155
ST10
ST19
ST10
ST10
ST469
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M73
B1
M74
B1
M75
B1
ST155
M76
B1
ST155
M78
A
ST10
M79
A
ST10
M80
B1
ST155
M81
A
ST10
M82
A
M83
A
M84
B2
ST95
M85
A
ST10
M86
B1
M87
A
ST398
M90
A
ST10
M91
A
ST10
M92
A
ST10
M93
A
M94
A
ST10
M95
ST23
M96
C
ST23
M97
B1
M98
B1
ST155
M99
B1
ST155
*Strains classified as mild mastitis are denoted in green and severe mastitis in red
ExPEC strains are frequently defined as those carrying two or more specific sets of
virulence genes [318,319]. These genes are involved in adhesion (P fimbriae; papAC and S
fimbriae; foc), capsule biosynthesis (Group 2&3 capsule; kpsM), and nutrient scavenging
(aerobactin receptor; iutA). Several of these genes were detected in the MAEC genomes, and
approximately seven strains met the strict criterion of ExPEC classification (Table 4.2). Since
mastitis severity could be associated with these genes or additional relevant virulence factors,
hierarchical clustering was performed, where each strain was grouped into a cluster based on the
presence or absence of virulence genes. These clusters were displayed as a dendrogram, which
shows the hierarchical relationship between virulence and mastitis scores for each strain. This
82

revealed that there was no apparent clustering of strains based on mastitis score and ExPEC
virulence genes (Fig. 4.2).
Table 4.2 Defined ExPEC* strains
Strain papC focC

kpsM iutA

Total

M40

1

1

1

0

3

M93

1

1

1

0

3

M45

0

1

0

1

2

M73

0

1

1

0

2

M84

1

0

1

0

2

M99

0

1

0

1

2

M102 0

1

0

1

2

*MAEC strains defined as ExPEC based on the carriage of 2 or more of 4virulence genes.
Strains classified as mild mastitis are denoted green and severe mastitis red
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Figure 4.2 Hierarchical clustering for 81 MAEC based on the carriage of 21 virulence genes
associated with the ExPEC phenotype.There does not appear to be any clustering into clades of
strains with either a mild or severe mastitis score
ExPEC are responsible for urinary tract, respiratory tract, bloodstream, and liver
infections in both humans and animals. Although these commonly studied ExPEC virulence
factors were not associated with mastitis severity, it does not rule out the possibility that they
contribute to the virulence of individual strains in MGs, as shown for the capsule and znu gene
cluster in Chapters 2 and 3 of this dissertation. Furthermore, additional factors that contribute to
ExPEC infections that are not on the list above could be associated with mastitis severity. The
presence of these classic ExPEC virulence genes in MAEC might suggest that these strains are
capable of causing infections in humans, including bloodstream or urinary tract infections.
“Human” ExPEC strains may also be capable of causing mastitis in dairy cattle.
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4.3.3 Differences in mastitis severity are not associated with differences in the core
genome
To explore if mastitis severity can be predominantly attributed to differences in the core
genome, we constructed a phylogenetic tree based on the core genome sequence alignment. In
this analysis, several ExPEC strains and one enterohemmorhagic strain were included as
references (Fig. 4.3A). The phylogenetic tree reveals the diversity of our MAEC strains.
Compared to the relatively tight clades of other ExPEC based on the few ExPECs included in the
analysis, the MAEC strains belong to a broad range of backgrounds, including a few that are
closely related to other ExPEC strains. This group of 10 strains that clustered closely with
ExPEC included nine severe and one mild strain. However, there was not a consistent clustering
into clades based on mastitis severity. We also analyzed the relationship between the core
genome and the geographical region where the strains were isolated (Fig. 4.3B). This showed
that both mild and severe strains were isolated from many different regions, and mild or severe
strains did not cluster to any particular region.
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Figure 4.3 Phylogenetic tree of the core genome
Grouping into clades based on mastitis severity or location isolated is not apparent (A) Strains
classified as mild mastitis are denoted green and severe mastitis red. (B) Regions strains isolated
where isolated are from Ontario, Quebec, Atlantic and Alberta and are labeled green, blue,
purple and red respectively. Strains labeled black were used as references.
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4.3.4 Association between plasmid content and mastitis severity
Plasmids contribute to bacterial diversity such as that demonstrated by MAEC strains, in
part because they can contribute to homologous or non-homologous recombination. They are
also frequently associated with carriage of specific fitness factors, which could be related to
mastitis severity. Plasmids are classified based on their incompatibility with other plasmids.
Incompatibility typing was performed for each of the MAEC strains [320,321]. Nineteen
different Inc groups were detected in the MAEC genome sequences, suggesting a wide diversity
of plasmid content. Multiple Inc types were frequently found in the same strain, suggesting the
possibility of hybrid plasmids. When compared to the severe MAEC strains, more Inc groups
were detected among the mild MAEC strains (Fig. 4.4A&B). IncF1B was the most commonly
detected group in both mild and severe strains. IncF1B and IncF1C were both more abundant in
mild strains than in severe strains.
As plasmids are the most important means of antibiotic resistance dissemination among
bacteria, carriage of antibiotic resistance genes among mild and severe mastitis strains was also
assessed in silico by searching a repository of antibiotic resistance genes [322]. This analysis
showed that 12 of 81 strains did carry one or more resistance genes. Notably, two severe strains
(M79 and M96) had nine genes each that confer resistance to seven antibiotic classes, including
aminoglycosides, beta-lactams, phenicols, trimethoprim, erythromycin, tetracyclines, and
sulfonamides. Overall, antibiotic resistance genes were evenly distributed between both mild and
severe MAEC strains suggesting that carriage of these genes does not affect mastitis severity
(Table 4.3).
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Figure 4.4 Plasmid replicons and incompatibility (Inc) groups found in mild and severe MAEC
strains
(A) Total plasmid replicons for both mild and severe strains. Mild strains had more replicons
found but were not significantly different from severe strains. (B) Each plasmid inc group
identified in both mild and severe strains. Only IncF1A and IncF1C where significantly enriched
in mild strains when compared to severe strains.
Table 4.3 Total antibiotic genes identified in MAEC* strains
Aminogly- BetaTrimetho- Erythro- Tetracoside
lactam Phenicol prim
mycin
cycline Sulfonamide Total
M79
3
1
1
1
1
1
1
9
M96
2
1
2
1
0
1
2
9
M51
4
0
1
1
0
1
1
8
M102
3
1
0
1
0
1
1
7
M110
4
1
0
1
0
0
1
7
M75
3
1
0
1
0
0
1
6
M99
2
1
0
1
0
1
1
6
M39
2
0
0
0
0
1
1
4
M70
1
0
0
1
0
0
1
3
M97
2
0
0
0
0
0
0
2
M87
0
0
0
0
0
1
0
1
M92
0
0
1
0
0
0
0
1
*Severe strains denoted in red and mild strains denoted in green.
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4.3.5 GWAS results
Genes found in the core genome only make up 20% of the pan-genome, with a majority
of genes found in the accessory genome of MAEC strains (Table 4.4). This suggested that an
approach based on gene presence and absence, rather than a SNP analysis of the core genome,
may be effective in identifying genes associated with mild or severe mastitis.
Table 4.4 Core and accessory genome
Core Genes

98%<= strains <=100%

3177

Soft Core Genes

95%<= strains <=98%

263

Shell Genes

15%<= strains <=95%

1523

Cloud Genes

0%<= strains <=15%

10432

Total Genes

0%<= strains <=100%

15395

The absence and presence of genes for our MAEC library were used to find those
associated with mastitis severity. The pan-GWAS tool Scoary analyzes each gene in the pangenome and scores it according to the mastitis severity phenotype's correlation. Each gene with
an apparent relationship to the phenotype is reanalyzed, incorporating information about the
phylogenetic structure to implicate genes associated with mastitis severity [323]. Scoary has
been used to identify bacterial genes associated with virulence, antibiotics resistance, and
environmental persistence [324-330]. Using this tool, we found 25 genes that were positively
associated with severe mastitis and 79 genes negatively associated with severe mastitis
(Supplemental Table S.3).
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Several genes involved in the biosynthesis and structure of yad fimbriae were positively
associated with severe mastitis. These genes were found in eight strains isolated from severe
mastitis cases and were not found in any strains from mild mastitis cases. Yad fimbriae are
composed of the tip/adhesin YadC along with fimbrial protein subunits encoded by yadMLKN
genes. Assembly requires the chaperone protein YadV and the fimbrial usher HtrE, similar to the
well-studied Pap fimbriae [331-333]. Of these genes, htrE, yadM, yadL, yadK, yadN, and yadV
were associated with severity. Yad fimbriae are enriched among ExPEC strains of APEC and
UPEC origin [54,56,334,335]. These fimbriae have not previously been ascribed a role in
mastitis pathogenesis. YadC is known to bind to the human intestinal cell line, Caco-2, and
bladder epithelial cells in vitro but it is not known its binding potential in the mammary gland
[53,336].
Genes found in the PGA putative exopolysaccharide and several tyrosine recombinases
were negatively associated with mastitis severity. The pgaABCD was detected in 39 of 40 strains
with a mild mastitis score and 33 of 41 strains with severe mastitis score. PGA polysaccharide is
necessary for some E. coli strains to produce biofilms in some conditions [337-340]. Synthesis of
PGA requires PgaA, PgaB, PgaC, and PgaD, and of these, only PgaD was detected in our
analysis using a significance cutoff of P-value of 0.05. Tyrosine recombinases are known to
mediate recombination of promoter elements that control the expression of certain virulence
genes [341-344]. They are also associated with bacteriophages, which likely increase diversity in
the MAEC population. We detected three different tyrosine recombinase alleles in 34, 31, and 10
mild strains, while 26, 18, and 2 were detected in severe strains (Supplemental table S.3).
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4.3.6 Tracking MAEC bacterial populations through experimental infections of murine
and bovine mammary glands
In the experiments described above, we analyzed the association of specific MAEC genes
with clinical severity as reported by veterinarians. Next, we were interested in whether strains
that tend to cause severe or mild disease were more or less fit within the mammary gland
environment. Traditionally, competition assays are used to compare the fitness of isogenic
mutants compared to a wild type strain. In Tn-Seq screens, thousands of mutants are tracked and
the contribution of each gene to fitness in a particular environment can be assessed. Competition
assays have also been occasionally used to compare relative fitness of different wild strains,
rather than isogenic mutants with their parent strain. We reasoned that multi-strain competition
assays might be paired with GWAS to identify genes associated with fitness in a specific
environment like mammary gland infections across populations, rather than within a single strain
background. To investigate this possibility, we developed a barcoding system where each strain
is tagged with a plasmid containing a unique 12 nucleotide sequence. To create these plasmids,
we modified the low copy pACYC184 plasmid, by removing the tetracycline resistance gene and
adding the 12 nucleotide sequence and part of the Illumina adapter sequence flanking the 5’ end
of the barcode. We then isolated each plasmid and determined the unique barcode using Sanger
sequencing. These plasmids were then transformed into 96 MAEC isolates.
These tagged MAEC strains were followed during competition in LB media, whole
unpasteurized milk, as well as mouse and cow mammary glands. An inoculum consisting of
equal numbers (500CFU) of each strain was prepared. The plasmids from the inoculum were
isolated to verify the starting numbers for each strain. The inoculum was added to duplicate
samples of LB broth or unpasteurized milk for in vitro growth. After 8 hours, the bacteria were
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recovered and then the plasmids isolated. The inoculum was also injected into 10 mammary
glands of lactating mice. After 24 hours, the glands were harvested, and the bacteria recovered
for 12 hours and the plasmids in the recovery population were isolated. The inoculum was also
injected into the mammary glands of lactating dairy cattle by collaborators at the USDA in
Ames, IA. They sampled the cows at 6, 11, 24, and 35 hours and collected milk samples, from
which the bacteria were grown and their plasmids isolated. All of the plasmid samples were
combined then sequenced en masse in order to count the occurrence of each barcode in each
library (2 LB, 2 milk, 6 mice, and 3 cattle). To count the barcodes in each sample library, we
pulled each barcode from the sequencing file for each condition. This analysis showed that 19
barcodes failed to sequence as they were not detected in the inoculum or any of the other plasmid
libraries. The abundance of each barcode is a direct measure of fitness for each strain in a given
condition compared to its competitors. The following equation expresses a strain's fitness in each
condition: (𝑊) =

𝑆𝑡𝑎𝑖𝑛 1 𝑏𝑎𝑟𝑐𝑜𝑑𝑒 𝑓𝑜𝑢𝑛𝑑 𝑖𝑛 𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚
)
𝑇𝑜𝑡𝑎𝑙 𝑏𝑎𝑟𝑐𝑜𝑑𝑒𝑠 𝑓𝑜𝑢𝑛𝑑 𝑖𝑛 𝑖𝑛𝑜𝑐𝑢𝑙𝑢𝑚
𝑆𝑡𝑟𝑎𝑖𝑛 1 𝑏𝑎𝑟𝑐𝑜𝑑𝑒 𝑓𝑜𝑢𝑛𝑑 𝑖𝑛 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛
( 𝑇𝑜𝑡𝑎𝑙 𝑏𝑎𝑟𝑐𝑜𝑑𝑒𝑠 𝑓𝑜𝑢𝑛𝑑 𝑖𝑛 𝑐𝑜𝑛𝑑𝑖𝑡𝑜𝑛 )

(

.

4.3.7 Fitness in milk and mouse mammary glands is not associated with mastitis severity
For those strains whose barcodes were compatible with Illumina sequencing, we were
able to calculate a competitive index during competition in LB broth in milk, and during
mammary gland infections. The log2 fitness score for mild and severe mastitis strains was
plotted, and a Mann-Whitney U test was performed to detect any associations between mastitis
severity and fitness in milk, mouse and cow MGs. No relationship between mastitis severity and
fitness in milk and mouse MG conditions could be detected; however, fitness in cow MG at 6
hours was significantly correlated with severity (Fig. 4.5B).
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Figure 4.5 Association between mild and severe mastitis severity and fitness in milk and mouse
and cow MGs
Log2 Fitness plotted for mild and severe strains in three conditions. Only cow MGs at 6 hr were
significant between mild and severe strains determined by a Mann-Whitney U test
4.3.8 Chitinase is associated with in vivo fitness in mouse mammary glands
We used Scoary to identify genes in the pan-genome that are associated with competitive
fitness in milk and in mouse and cow MGs. For this analysis, we separated the top and bottom
30% of strains for each condition based on their fitness scores. Five genes were positively
associated with good milk growth, including a predicted inner membrane protein yjeO, three
genes with unknown function, and an IS3 family transposase, insK. In mouse MGs, there were
38 genes positively associated with colonization. Notably, 14 of these genes are involved in a
type 2 secretion system found in two operons (gspC-O and gspAB) as well as the chitinase
encoded by chiA. In the non-pathogenic K12 strain, transcription of this type 2 secretion system
is normally repressed by the Hns protein, and the full gsp locus is needed for proper chiA
secretion [345]. Besides chitinase, several other substrates of type II secretion systems have been
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shown to be important for pathogenesis of other E. coli, including toxins, proteases, and surface
proteins of intestinal pathogenic strains and the DraD invasin protein found in some
uropathogenic strains.
In mammals, chitin acts as a potential microbial-associated molecular pattern, recognized
by host proteins including the glycoside hydrolase family 18 proteins (GH18). These chitinaselike proteins help protect against chitin-containing pathogens like fungi [346-349]. Interestingly,
expression of host chitin-like proteins is also induced by some bacterial pathogens [350]. The
chitinase-like protein CHI3L1 regulates innate immune defenses against Streptococcus
pneumoniae and Pseudomonas aeruginosa lung infections through inhibition of caspase-1dependent macrophage pyroptosis [351,352]. Conversely, CHI3L1 expressed by intestinal
epithelial cells during inflammatory bowel diseases helps facilitate enteric bacterial infection.
ChiA proteins in have been implicated in the virulence of some adherent/invasive E. coli strains
that cause colitis. This is not due to their chitinolytic activity, but rather because of chitinbinding domains that are found in the N terminus of the protein. These domains mediate binding
to CHI3L1, which is expressed on the surface of intestinal epithelial cells, leading to subsequent
invasion of the bacteria [353,354]. Recently, CHI3L1 was also found in the milk secretions of
coliform-affected quarters in bovine mastitis. CHI3L1 gene expression is also increased in
mouse MGs following E. coli infection. In knockout mice lacking CHI3L1, bacterial growth is
not affected, but the influx of neutrophils into the lumen of the infected gland is reduced [355].
Our GWAS results suggest the possibility that some MAEC strains may bind to CHI3L1 via
ChiA on mammary epithelial cells, which could lead to subsequent invasion.
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4.3.9 Rhamnose biosynthesis genes are positively correlated with fitness in cow
mammary gland infections
Two genes that were positively associated with colonization in the cow MG
were rfbA and rfbD, both of which are involved in dTDP-L-rhamnose biosynthesis. Rhamnose is
an important sugar in both the O-antigen and capsule polysaccharides in E. coli; copies of these
genes can be found in loci involved in O-antigen biosynthesis and type III capsule production.
For example, the MAEC M12 strain incorporates rhamnose in both its O-antigen and capsule. As
shown in Chapters 2-3, the rhamnose-containing capsule of strain M12 is a critical virulence
factor for colonizing mammary glands, kidneys and spleens during mouse infections.
Additionally, the O-antigen is a well-documented virulence factor for many Gram-negative
bacteria. It is possible that O-antigens containing rhamnose also provide an advantage during
mammary gland infections. Possible mechanisms include promoting resistance to complement,
which is known to accumulate in the mammary glands during mastitis infections.
The gsp locus and chiA were not positively associated with colonization in the cow MG.
This may be due to collection differences in the two infection models. Because of the inability to
harvest mammary gland tissues from infected cattle, we were limited to collecting milk samples
expressed from infected udders in order to recover the barcoded bacteria. This is in contrast to
the mouse infections, where whole infected mouse MGs tissue were homogenized to recover
bacteria. This would underrepresent adhesive or intracellular bacteria from cows, while the
mouse MG would be expected to contain the whole bacterial population.
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4.4 Conclusions
In Chapter 2 of this dissertation MAEC strain M12 was characterized, leading to
identification of virulence factors needed by this strain to colonize mammary glands and to
disseminate. In this Chapter, I took a broader approach, sequencing 83 MAEC genomes and
identifying several genes associated with their clinical manifestation and fitness in relevant
models of disease. Through this process, I determined that this group of MAEC strains are
genetically diverse, belonging to several MLSTs and carrying several virulence factors
associated with ExPEC strains. Utilizing a pan-genome wide association approach, I identified
genes involved in adherence and biofilm formation associated with mild and severe mastitis;
these include the Yad fimbriae and PGA exopolysaccharide. Additionally, I developed a
barcoding system where multiple strains can be tracked as they compete in different conditions.
These barcoding experiments consisted of competing 96 strains in milk and MGs of mice and
cows. I identified the potential role of ChiA in adherence and of rhamnose in fitness in the mouse
and cow mammary glands, respectively. Interestingly, rhamnose is often found in the O-antigen
and type III capsules. These findings are summarized in Figure 4-6.
These studies are also significant in that they reveal several factors that do not seem to
contribute to mastitis severity and/or fitness in experimental infections. Consistent with other
groups, we were unable to find an association between growth in milk and mastitis severity. We
identified 19 different Inc plasmid groups in our MAEC strains, which often carry virulence and
antibiotic resistance genes, and found that mild mastitis strains had significantly more Inc groups
than severe strains. However, we did not investigate whether any virulence or antibiotic genes
were found on these plasmids. Antibiotic resistance is a significant health and environmental
concern. In our study population only 12 of the 83 strains carried one or more genes implicated
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in antibiotic resistance. Two strains carried genes that confer resistance to seven different classes
of antibiotics. Carriage of antibiotic resistance genes did not appear to correlate with disease
severity.
A phylogenetic analysis of the core genome highlighted this genetic diversity and showed
that only a few MAEC strains were closely related to other sequenced ExPEC strains.
Interestingly, we could not find an apparent relationship between mastitis severity with the
phylogroup, MLST, or core genome; these results lead us to use a more sophisticated approach
to tease out a relationship between mastitis severity and the accessory genome. Using a pangenome wide association approach, we identified several genes associated with either a mild or
severe mastitis clinical score. This includes the Yad fimbriae, which were positively associated
with mastitis severity, and conversely, the PGA exopolysaccharide was negatively associated
with mastitis severity. Additionally, we identified a chitinase and rhamnose biosynthesis genes
associated with colonization of a mouse and cow MG, respectively. How each of these systems
are involved in mastitis should be the subject of future investigation.
The model presented in Figure 4-6 suggests that Yad fimbriae are involved in attachment
to mammary epithelial cells. This could be tested by comparing a strain that constitutively
expresses Yad fimbriae with a yadC mutant’s attachment to a bovine mammary epithelial cell
line. Furthermore, a yadC mutant could be assessed for its colonization in a MG. The role of
chitinase in attachment to mammary gland epithelia can be studied in a similar way. Surface
expression of CHI3L1 should be verified in mammary epithelia in vitro and in vivo. Dependence
on specific domains of ChiA in attachment can also be investigated.
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The model suggests that PGA may lessen mastitis severity by shielding inflammatory
mediators. This can be directly tested by measuring pro-inflammatory cytokines and ROS
markers in a mouse mastitis model infected with either a wild type or PGA mutant strain.
Rhamnose sugars present in capsule or O-antigens may enable MAEC strains to avoid
phagocytic killing in mammary glands. This can be tested by deleting the rml genes found in the
O-antigen or capsule and determine if there is an increase in in vitro phagocytosis or decrease in
bacterial load in the mammary gland. Additionally, the region 2 can be replaced in the capsule by
a different region 2 from a group 3 capsule that lacks rhamnose. This modified strain then can be
subsequently assessed for virulence and susceptibility to phagocytosis.
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Figure 4.6 Putative function of genes implicated by a pan-GWAS analyses in mastitis.
(A) Yad fimbriae were positively associated with severe mastitis; these CU fimbriae are likely
involved in attachment. The binding ligand of YadC in the context of mastitis is unknown but
presumably binds to the mammary gland epithelium. (B) After attachment, strains associated
with mild mastitis may form biofilms. This biofilm production could shield pathogen-associated
molecular patterns, specifically LPS, from the innate immune system, thus decreasing
inflammation. (C) The chitinase, ChiA, is secreted by a type II secretion system and was
associated with high colonization of mouse MGs. A potential mechanism consists of ChiA
binding CH3L1 mediated by the chitin binding domains found in the N-terminus of the protein.
(D) In chapters two and three of this dissertation I investigate the importance of type III capsules
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in colonizing multiple tissue sites and an insect model. Rhamnose is often found in the O-antigen
and type III capsules. Two rhamnose biosynthesis genes were associated with high colonization
of cow MGs. Capsules are important in protecting bacteria from host immune factors which
include phagocytic cells, compliment and antimicrobial peptides. The specific role of rhamnose
needs to be further investigated.
4.5 Materials and methods
4.5.1 Bacterial strains and growth conditions
Escherichia coli strains M22-M117 were generously supplied by Jeroen De Buck
(University of Calgary Veterinary Medicine, Calgary, Canada). Strains were isolated from
individual quarter milk samples from cattle with clinical mastitis and were given a severity score
based on mastitis's clinical manifestation. Putative E. coli were identified phenotypically by
colony morphology on blood and MacConkey agar plates and confirmed genotypically. Bacteria
were routinely grown in Luria-Bertani (LB) medium at 37°C. For milk cultures, whole,
unpasteurized cow's milk was obtained from a local supplier and used immediately or stored at
−80°C until use.
4.5.2 MAEC sequencing, assembly, and annotation
Total DNA was isolated from 83 MAEC strains using a ZR Fungal/Bacterial DNA
MiniPrep kit (Zymoresearch). DNA sequencing libraries were prepared using the Illumina
Nextera DNA Library Prep kit with modifications [290]. DNA libraries were sequenced by
Genewiz, Inc. (South 330Plainfield, NJ), and Illumina paired-end reads of 150 bp were generated
on MiSeq version 2 sequencer. Contigs were assembled, and in silico determination of
phylogroup and MLST using EnteroBase and genomes were annotated using Prokka
[291,292,356].
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4.5.3 Pan-genome, core genome alignment and phylogenetic tree
Pan-genome was generated using Roary, using 90% minimum percentage identity for
blastp, and genes needed to be considered to be part of the core genome needed to be present in
98% of strains (i.e., a gene could be missing in only one strain and still be considered part of the
core genome)[314]. Roary output files included a core genome alignment made using
PRANK[357], and a gene absence/presence Rtab file. The core genome alignment was used to
create a maximum-likelihood phylogenetic tree using IQ-Tree, and the subsequent tree was
visualized using Interactive Tree Of Life [358-360]
4.5.4 Detection of plasmids and antibiotic resistance genes
The PlasmidFinder 2.1 database at the Center for Genomic Epidemiology
(https://cge.cbs.dut.dk/services/PlasmidFinder) was used to detect and type plasmids found in
MAEC genomes. Assembled reads for each strain were searched using the most recent
Enterobacteriaceae plasmid database (2020-04-02) using 90% minimum identity and 60%
minimum % coverage cutoffs. Inc groups that were found in each strain were recorded.
Associations of the Inc group with strain type (mild or severe mastitis strains) were assessed
using Fisher's exact test. Each Inc group was counted individually even when multiple Inc
groups were detected in a single strain. ABRicate software
(https://github.com/tseemann/abricate) was used to find genes implicated in antibiotic resistance
from the Resfinder database [361].
4.5.5 Creation of barcoded plasmid and barcode sequencing
We modified the low copy pACYC184 plasmid, by generating PCR products with a
partial illumina adapter flanking 12 random nucleotides, and pACYC184 overhangs and the
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pACYC184 backbone lacking the tetracycline resistance gene. These PCR products were
stitched together by overlap extension and transformed into DHα. 96 plasmids were isolated and
the barcode sequence was determined by Sanger sequencing. After growth in milk and MG
infection we used PCR to add the rest of the illumina adapter and amplify the barcode. DNA
libraries were sequenced by Genewiz, Inc. (South Plainfield, NJ) and CD-Genomics, inc. (Shirly,
NY) and Illumina paired-end reads of 150 bp were generated on MiSeq version 2 sequencer. To
identify barcodes for each strain from the Illumina sequence reads a custom grep function was
used.
4.5.6 Mouse infections
Lactating C57BL/6 mice between 9 and 12 weeks of age and 10 to 11 days postpartum
were infected as previously described [245]. Briefly, a 50 µl volume of bacteria containing 500
CFU of each strain for total of ~50,000 CFU was suspended in PBS. The inoculum was injected
directly through the teat canal into the ductal network of the 4th left and 4th right mammary
glands of 6 mice using a 33-gauge needle with a beveled end. Pups were removed for 1 to 2 h
after injections and then were returned. Mice were euthanized after 24 h and mammary gland
tissue was harvested.
4.5.7 pan-GWAS
To identify genes found in the accessory genome that are associated with each phenotype
the pan-GWAS tool Scoary was used version 1.6.16. Input files consisted of a gene
absence/presence Rtab file generated by Roary and a custom trait file which assigned a discrete
phenotype for each strain. A naive P-value less than 0.05 was used to determine significance for
each gene.
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Chapter 5
Supplemental figures

Figure S.1 Reproducibility between biological replicates in Tn-seq experiments.
Insertion counts for each gene were tabulated for replicates R1 and R2 for each library (LB
broth, milk, G. mellonella, mammary glands and spleens). Each dot represents the R1 vs R2
insertions for a single gene. A linear regression analysis was used to determine the correlations.
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Figure S.2 Fitness costs (Log2fitness score) associated with disruptions to M12 stress resistance
genes in milk, G. mellonella, or during mouse infections as measured by Tn-seq.

Figure S.3 Design and workflow for Tn-seq experiments
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Figure S.4 Complementation of znuABC and growth in manganese and copper
(A) Complement grows with the same kinetics as the wild type in LB+ Bile salts (B)
Complementation via low a low copy plasmid grow to the same levels as the wild type in EDTA.
The znuABC mutants growth is attenuated but the addition of zinc restores growth to wild type
and complement levels. (C&D) Manganese and zinc does not restore growth of the znuABC
mutant in EDTA.
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Supplemental tables
Table S.1 Genes with lowest fitness score in four conditions
Milk
Function
Biotin operon repressor / Biotin-protein ligase (EC 6.3.4.15)
Ribulose-phosphate 3-epimerase (EC 5.1.3.1)
6-phosphofructokinase (EC 2.7.1.11)
Phosphoribosylaminoimidazole carboxylase catalytic subunit (EC 4.1.1.21)
Phosphoribosylamine--glycine ligase (EC 6.3.4.13)
Regulatory protein Cro of bacteriophage BP-933W
Primosomal protein I
Tyrosine recombinase XerC
Phage repressor
FIG00639586: hypothetical protein
Phosphoadenylyl-sulfate reductase [thioredoxin] (EC 1.8.4.8)
hypothetical protein
3-isopropylmalate dehydrogenase (EC 1.1.1.85)
Chorismate mutase I (EC 5.4.99.5) / Prephenate dehydratase (EC 4.2.1.51)
Glucosamine-6-phosphate deaminase (EC 3.5.99.6)
Argininosuccinate lyase (EC 4.3.2.1)
tolB protein precursor, periplasmic protein involved in the tonb-independent uptake of group A colicins
Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1)
Phage antitermination protein Q
IMP cyclohydrolase (EC 3.5.4.10) / Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3)
Bis(5'-nucleosyl)-tetraphosphatase, symmetrical (EC 3.6.1.41)
Chorismate synthase (EC 4.2.3.5)
COG1451: Predicted metal-dependent hydrolase
Ketol-acid reductoisomerase (EC 1.1.1.86)
Cystathionine beta-lyase (EC 4.4.1.8)
G. mellonella
DeoR-type transcriptional regulator YihW
Biotin operon repressor / Biotin-protein ligase (EC 6.3.4.15)
Flagellar basal-body rod protein FlgB
FIG00643789: hypothetical protein
Agmatinase (EC 3.5.3.11)

Log2 Fitness Score
-25.002
-14.559
-14.316
-14.114
-14.047
-14.021
-13.875
-13.733
-13.474
-13.451
-13.437
-13.426
-13.402
-13.388
-13.314
-13.171
-13.126
-13.012
-13.008
-12.977
-12.86
-12.645
-12.553
-12.446
-12.383

p Value
2.01E-06
5.25E-12
2.93E-09
6.83E-19
2.00E-16
2.97E-13
8.47E-08
6.54E-06
0.00108
8.02E-12
3.54E-05
2.26E-06
9.43E-09
2.89E-18
3.09E-12
1.73E-11
2.25E-09
3.89E-26
1.86E-89
9.55E-40
5.04E-08
0.02805
0.02943
1.59E-24
6.93E-16

-25.911
-24.62
-24.275
-17.154
-14.607

5.83E-13
1.14E-06
1.23E-10
1.18E-07
6.80E-15
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FIG00639586: hypothetical protein
3-carboxyethylcatechol 2,3-dioxygenase (EC 1.13.11.16)
methylated-DNA--protein-cysteine methyltransferase-related protein
Ribulose-phosphate 3-epimerase (EC 5.1.3.1)
Siroheme synthase / Precorrin-2 oxidase (EC 1.3.1.76) / Sirohydrochlorin ferrochelatase (EC 4.99.1.4) / Uroporphyrinogen-III methyltransferase (EC 2.1.1.107)
FIG00638997: hypothetical protein
Possible protease sohB (EC 3.4.21.-)
Inosine-guanosine kinase (EC 2.7.1.73)
Nitrate/nitrite transporter NarK
FIG00637875: hypothetical protein
Phosphoheptose isomerase (EC 5.3.1.-)
23S rRNA (Uracil-5-) -methyltransferase rumB (EC 2.1.1.-)
Alpha-ketoglutarate permease
Hydrogen peroxide-inducible genes activator
Nucleoside diphosphate kinase (EC 2.7.4.6)
Zinc ABC transporter, ATP-binding protein ZnuC
Primosomal protein I
Putative LysR-family transcriptional regulator YidZ
tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA
RNA polymerase sigma factor FecI
Mammary Gland
Alkanesulfonate monooxygenase (EC 1.14.14.5)
Phospholipase/carboxylesterase family protein (EC 3.1.-.-)
Biotin operon repressor / Biotin-protein ligase (EC 6.3.4.15)
Flagellar basal-body rod protein FlgB
Phosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19) / Phosphoribosyl-ATP pyrophosphatase (EC 3.6.1.31)
Mobile element protein
Glutamate Aspartate transport ATP-binding protein GltL (TC 3.A.1.3.4)
Cystathionine beta-lyase (EC 4.4.1.8)
methylated-DNA--protein-cysteine methyltransferase-related protein
tolB protein precursor, periplasmic protein involved in the tonb-independent uptake of group A colicins
Carbamoyl-phosphate synthase large chain (EC 6.3.5.5)
Methionine repressor MetJ
Zinc transporter ZupT
Phosphoheptose isomerase (EC 5.3.1.-)
Phosphoribosylamine--glycine ligase (EC 6.3.4.13)
Regulatory protein Cro of bacteriophage BP-933W
Protein sprT
Succinate dehydrogenase flavoprotein subunit (EC 1.3.99.1)

-14.594
-14.378
-14.281
-14.25
-14.222
-14.188
-14.184
-13.929
-13.835
-13.833
-13.796
-13.739
-13.708
-13.667
-13.64
-13.62
-13.566
-13.564
-13.496
-13.484

4.08E-14
1.47E-19
3.68E-18
4.79E-12
5.56E-45
5.63E-16
7.52E-16
4.60E-14
4.95E-14
1.13E-18
1.20E-09
2.24E-13
4.28E-14
2.75E-14
1.51E-09
5.00E-14
6.35E-08
1.92E-08
1.79E-05
1.16E-05

-30
-24.392
-24.075
-23.522
-21.562
-15.788
-14.268
-14.029
-13.817
-13.809
-13.57
-13.5
-13.368
-13.332
-13.274
-13.253
-13.234
-13.157

4.72E-36
1.49E-12
4.87E-07
6.54E-11
6.64E-06
4.41E-06
1.07E-18
2.21E-15
3.06E-18
1.57E-11
3.31E-14
3.56E-14
3.17E-17
6.96E-10
2.28E-16
1.67E-13
8.57E-17
1.12E-12
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Head decoration protein
Primosomal protein I
Biotin synthesis protein BioH
Exodeoxyribonuclease III (EC 3.1.11.2)
Branched-chain amino acid aminotransferase (EC 2.6.1.42)
Phage antitermination protein Q
Polyphosphate kinase (EC 2.7.4.1)

-13.132
-13.102
-13.098
-13.022
-12.89
-12.875
-12.873

5.71E-14
3.74E-08
2.51E-13
7.31E-14
2.13E-15
7.11E-11
1.59E-06

-23.803
-20.962
-15.478
-12.856
-12.824
-12.533
-12.441
-12.142
-11.994
-11.982
-11.975
-11.956
-11.822
-11.814
-11.804
-11.704
-11.642
-11.631
-11.457
-11.453
-11.368
-11.361
-11.35
-11.31
-11.308

1.85E-11
2.59E-05
6.56E-06
3.43E-12
2.23E-15
2.04E-13
4.64E-14
9.42E-13
0.00029
2.32E-14
1.49E-09
2.83E-06
9.11E-11
3.16E-08
1.29E-06
3.19E-13
8.97E-10
2.58E-10
9.40E-07
0.02544
1.50E-09
0.02671
1.06E-09
6.86E-11
1.85E-07

Spleen
Phospholipase/carboxylesterase family protein (EC 3.1.-.-)
Phosphoribosyl-AMP cyclohydrolase (EC 3.5.4.19) / Phosphoribosyl-ATP pyrophosphatase (EC 3.6.1.31)
Cyd operon protein YbgE
23S rRNA (Uracil-5-) -methyltransferase rumB (EC 2.1.1.-)
Putative protease
FIG01046209: inner membrane protein
tRNA (guanine46-N7-)-methyltransferase (EC 2.1.1.33)
Enterobactin exporter EntS
Guanine deaminase (EC 3.5.4.3)
LsrR, transcriptional repressor of lsr operon
Ribulose-phosphate 3-epimerase (EC 5.1.3.1)
Arginine pathway regulatory protein ArgR, repressor of arg regulon
FIG00639671: hypothetical protein
FIG00639097: hypothetical protein
FKBP-type peptidyl-prolyl cis-trans isomerase FklB (EC 5.2.1.8)
FIG002095: hypothetical protein
Syd protein
DNA helicase IV
Orotate phosphoribosyltransferase (EC 2.4.2.10)
Chorismate synthase (EC 4.2.3.5)
FIG00638000: hypothetical protein
COG1451: Predicted metal-dependent hydrolase
FIG00545237: hypothetical protein
Head decoration protein
Membrane Protein Functionally coupled to the MukBEF Chromosome Partitioning Mechanism

109

Table S.2 Top 25 genes with lowest fitness score in four conditions
Milk
Amidophosphoribosyltransferase (EC 2.4.2.14)
G. mellonella
Membrane fusion protein of RND family multidrug efflux pump
Multiple antibiotic resistance protein MarC
D-cysteine desulfhydrase (EC 4.4.1.15)
Cystine ABC transporter, permease protein
Beta-lactamase class C and other penicillin binding proteins
Cytochrome c heme lyase subunit CcmF
Cation efflux system protein CusF precursor
Cobalt-zinc-cadmium resistance protein
DNA-binding heavy metal response regulator
Amidophosphoribosyltransferase (EC 2.4.2.14)
DedA protein
tRNA pseudouridine synthase A (EC 4.2.1.70)
Cytoplasmic copper homeostasis protein CutC
Copper resistance protein CopC
Inhibitor of vertebrate lysozyme precursor
16 kDa heat shock protein A
16 kDa heat shock protein B
Macrolide export ATP-binding/permease protein MacB (EC 3.6.3.-)
Multidrug-efflux transporter, major facilitator superfamily (MFS) (TC 2.A.1)
Type I secretion outer membrane protein, TolC precursor
Quinolinate synthetase (EC 2.5.1.72)
Two-component response regulator CreB
Zinc resistance-associated protein
MG
Cystine ABC transporter, ATP-binding protein
Cystine ABC transporter, permease protein
Arsenical resistance operon repressor
Arsenical resistance operon trans-acting repressor ArsD
Arsenical pump-driving ATPase (EC 3.6.3.16)
Beta-lactamase (EC 3.5.2.6)
Cobalt-zinc-cadmium resistance protein
Amidophosphoribosyltransferase (EC 2.4.2.14)
tRNA pseudouridine synthase A (EC 4.2.1.70)
Multiple antibiotic resistance protein MarA
Copper resistance protein D
110

Cytoplasmic copper homeostasis protein CutC
Periplasmic divalent cation tolerance protein CutA
Inhibitor of vertebrate lysozyme precursor
16 kDa heat shock protein A
16 kDa heat shock protein B
Outer membrane lipoprotein YidQ
Uncharacterized protein YidS
Macrolide-specific efflux protein MacA
Membrane fusion protein of RND family multidrug efflux pump
RND efflux system, inner membrane transporter CmeB
Type I secretion outer membrane protein, TolC precursor
Inner membrane component of tripartite multidrug resistance system
Membrane fusion component of tripartite multidrug resistance system
Outer membrane component of tripartite multidrug resistance system
Multiple antibiotic resistance protein marC
L-aspartate oxidase (EC 1.4.3.16)
Inner membrane protein CreD
Two-component response regulator CreB
Two-component response regulator CreC
Response regulator of zinc sigma-54-dependent two-component system
Sensor protein of zinc sigma-54-dependent two-component system
Zinc resistance-associated protein
Spleen
Multiple antibiotic resistance protein MarC
D-cysteine desulfhydrase (EC 4.4.1.15)
Cystine ABC transporter, ATP-binding protein
Cystine ABC transporter, permease protein
Arsenical resistance operon trans-acting repressor ArsD
Beta-lactamase class C and other penicillin binding proteins
Cytochrome c heme lyase subunit CcmF
DNA-binding heavy metal response regulator
Amidophosphoribosyltransferase (EC 2.4.2.14)
tRNA pseudouridine synthase A (EC 4.2.1.70)
Copper resistance protein D
Copper resistance protein CopC
internalin, putative
Internalin-like protein (LPXTG motif) Lmo0331 homolog
Multidrug-efflux transporter, major facilitator superfamily (MFS) (TC 2.A.1)
RND efflux system, outer membrane lipoprotein, NodT family
Transcription repressor of multidrug efflux pump acrAB operon, TetR (AcrR) family
Type I secretion outer membrane protein, TolC precursor
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Multiple antibiotic resistance protein MarR
Quinolinate phosphoribosyltransferase [decarboxylating] (EC 2.4.2.19)
Quinolinate synthetase (EC 2.5.1.72)
Multidrug transporter MdtB
Multidrug transporter MdtD
Two-component response regulator CreC
Sensor protein of zinc sigma-54-dependent two-component system
Zinc resistance-associated protein
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Table S.3 Genes associated with mild and severe mastitis
Gene
group_4196
group_7009
xerC_5
group_4169
group_6919
wbpI
capD
yadV
yadM
yadK
htrE
group_1730
group_4172
group_3938
group_181
xapA
xapB
group_2791
group_6211
group_7074
group_7075
group_2857
pgaD
group_3896
xerC_1
cfaE
group_4171
hcaR_2
group_611
ygcB
casB
group_1716
hpcD
traA
group_108

Annotation
hypothetical protein
hypothetical protein
Tyrosine recombinase XerC
hypothetical protein
hypothetical protein
UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate
2-epimerase
UDP-glucose 4-epimerase
putative fimbrial chaperone YadV
putative fimbrial-like protein YadM
putative fimbrial-like protein YadK
Outer membrane usher protein HtrE
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
Purine nucleoside phosphorylase 2
Xanthosine permease
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
Biofilm PGA synthesis protein PgaD
hypothetical protein
Tyrosine recombinase XerC
CFA/I fimbrial subunit E
hypothetical protein
Hca operon transcriptional activator HcaR
hypothetical protein
CRISPR-associated endonuclease/helicase Cas3
CRISPR system Cascade subunit CasB
hypothetical protein
5-carboxymethyl-2-hydroxymuconate Deltaisomerase
Pilin
hypothetical protein

Number_pos_present_in Number_neg_present_in Naive_pValue
0
8
0.002390999
0
8
0.002390999
18
31
0.002960427
3
13
0.005332593
3
13
0.005332593
8
8
8
8
8
8
6
1
15
26
28
28
13
0
0
0
0
34
18
2
9
1
29
29
12
12
21

0
0
0
0
0
0
17
9
27
36
37
37
3
6
6
6
6
40
29
10
1
8
37
37
3
3
31

0.005361633
0.005361633
0.005361633
0.005361633
0.005361633
0.005361633
0.006887335
0.007016507
0.007579086
0.007767909
0.010514646
0.010514646
0.010514646
0.011827132
0.011827132
0.011827132
0.011827132
0.011827132
0.01313082
0.013145824
0.014477005
0.014477005
0.020096976
0.020096976
0.020096976
0.020096976
0.020122501

21
20
18

10
30
28

0.02203757
0.02203757
0.024926147

group_1666
group_430
hscC_2
dgcT
rop
rbsR_1
group_2745
group_2744
intS_2
group_6946
group_6523
group_6522
scrK
cscB
sacA
group_6524
group_1829
traS
group_1207
fliD
sopB
group_3898
group_3899
group_77
cbeA_2
ygbF
casE
casD
ygbT
casC
group_74
group_130
group_3956
group_2730
lexA_1
group_1246
vapB_1
vapC_1
yadL
group_4074
yadN

putative protein
hypothetical protein
Chaperone protein HscC
putative diguanylate cyclase DgcT
Regulatory protein rop
Ribose operon repressor
hypothetical protein
hypothetical protein
Prophage integrase IntS
hypothetical protein
hypothetical protein
hypothetical protein
Fructokinase
Sucrose permease
Sucrose-6-phosphate hydrolase
hypothetical protein
hypothetical protein
Protein TraS
hypothetical protein
Flagellar hook-associated protein 2
Protein SopB
hypothetical protein
hypothetical protein
hypothetical protein
Cytoskeleton bundling-enhancing antitoxin CbeA
CRISPR-associated endoribonuclease Cas2
CRISPR system Cascade subunit CasE
CRISPR system Cascade subunit CasD
CRISPR-associated endonuclease Cas1
CRISPR system Cascade subunit CasC
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
LexA repressor
hypothetical protein
Antitoxin VapB
tRNA(fMet)-specific endonuclease VapC
putative fimbrial-like protein YadL
hypothetical protein
putative fimbrial-like protein YadN

29
2
6
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
16
14
15
28
28
13
13
13
13
13
24
24
1
1
1
1
1
1
8
8
8

18
9
0
40
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
13
26
24
25
36
36
4
4
4
4
4
33
33
7
7
7
7
7
7
1
1
1

0.024926147
0.025510136
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025681773
0.025852165
0.026412826
0.026412826
0.026600538
0.027356318
0.027356318
0.027356318
0.027356318
0.027356318
0.027356318
0.027356318
0.027798065
0.027798065
0.02912671
0.02912671
0.02912671
0.02912671
0.02912671
0.02912671
0.02912671
0.02912671
0.02912671

group_464
group_1637
group_3203
group_5265
group_2040
group_2041
group_930
flxA
group_918
yadN
ymdA
rsmI_1
group_6103
lexA_2
repB
xerC_5
group_6216
traM
group_2566
group_187
group_7003
group_7004
group_266
group_374
casA
gnsA_2
htrE
hokE_3

hypothetical protein
hypothetical protein
hypothetical protein
ISKra4 family transposase ISCep1
hypothetical protein
hypothetical protein
ISAs1 family transposase ISEc26
Protein FlxA
ISNCY family transposase ISEsa1
putative fimbrial-like protein YadN
putative protein YmdA
IS66 family transposase ISEc43
hypothetical protein
LexA repressor
RepFIB replication protein A
Tyrosine recombinase XerC
hypothetical protein
Relaxosome protein TraM
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
IS5 family transposase IS903
CRISPR system Cascade subunit CasA
Protein GnsA
Outer membrane usher protein HtrE
Toxic protein HokE

8
8
5
5
5
5
22
22
22
30
38
21
21
11
26
26
6
6
15
25
2
2
2
4
12
29
29
29

1
17
13
13
13
13
31
31
31
37
30
30
30
20
34
34
14
14
24
33
8
8
8
11
4
36
36
36

0.02912671
0.031669017
0.034564852
0.034564852
0.034564852
0.034564852
0.035163626
0.035163626
0.035163626
0.037217407
0.037217407
0.03822861
0.03822861
0.040826103
0.041480192
0.041480192
0.041480192
0.041480192
0.046122555
0.047942068
0.048049246
0.048049246
0.048049246
0.048843968
0.048843968
0.048843968
0.048843968
0.048843968
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